{"content":"<li class=\"n-box-item date-title\" data-end=\"1523073599\" data-start=\"1522987200\" data-txt=\"Monday, December 23, 2019\">Friday, April  6, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3344275\" data-ts=\"1523055242\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNO\" target=\"_blank\">VNO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344275-vornado-handshake-to-sell-stake-in-kushner-building-sharesplus-5_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vornado has &#39;handshake&#39; to sell stake in Kushner building; shares +5.6%</a></h4><ul>   <li>Vornado Realty Trust (NYSE:<a href='https://seekingalpha.com/symbol/VNO' title='Vornado Realty Trust'>VNO</a>) has a \"handshake\" deal to <a href=\"https://www.bloomberg.com/news/articles/2018-04-06/vornado-has-handshake-to-sell-stake-in-nyc-tower-to-kushner\" target=\"_blank\">sell its stake in 666 Fifth Ave</a>. to Kushner Cos., its partner in the building run by the family of the president's son-in-law.</li>    <li>Vornado is <font color='green'>up 5.6%</font> after hours.</li>    <li>The deal will \"repay our investment plus a mezzanine-type return,\" Vornado Chairman/CEO Steven Roth writes in a <a href=\"https://seekingalpha.com/filing/3970302\" target=\"_blank\">letter to shareholders</a>.</li>    <li>Vornado had taken on a 49.5% stake in the tower as part of a 2011 refinancing; Kushner said it was negotiating to retake the stake in February.</li>    <li>Kushner Cos. had bought the building for a record-setting $1.8B just before the global financial crisis.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344275\" data-linked=\"Vornado has &#39;handshake&#39; to sell stake in Kushner building; shares +5.6%\" data-tweet=\"$VNO - Vornado has &#39;handshake&#39; to sell stake in Kushner building; shares +5.6% https://seekingalpha.com/news/3344275-vornado-handshake-to-sell-stake-in-kushner-building-sharesplus-5_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3344275-vornado-handshake-to-sell-stake-in-kushner-building-sharesplus-5_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344273\" data-ts=\"1523054652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAL\" target=\"_blank\">AAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344273-american-airlines-orders-47-new-boeings-ending-airbus-order\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Airlines orders 47 new Boeings, ending Airbus order</a></h4><ul>   <li>American Airlines (NASDAQ:<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group'>AAL</a>) has <a href=\"https://seekingalpha.com/pr/17122926-american-airlines-expands-boeing-787-fleet\" target=\"_blank\">ordered 47 new Boeing 787 widebody craft</a> (NYSE:<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a>), a contested deal that confirms the end of American's order with Airbus (<a href='https://seekingalpha.com/symbol/EADSY' title='Airbus SE ADR'>OTCPK:EADSY</a>). The Boeing order's <a href=\"https://seekingalpha.com/pr/17122929-boeing-american-airlines-sign-major-order-47-787-dreamliners\" target=\"_blank\">valued at $12B</a>.</li>    <li>Airbus and American have agreed to terminate an order for 22 A350s that was originally placed by US Airways.</li>    <li><a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group'>AAL</a> is <font color='green'>up 3.7%</font> in last after-hours trading; <a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='red'>down 0.3%</font>.</li>    <li>The 47 new Boeing craft consist of 22 787-8s scheduled to begin arriving in 2020, and 25 787-9s to begin arriving in 2023.</li>    <li>The 787-8s will replace American's Boeing 767-300s, while 787-9s will replace Airbus A330-300s and older 777-200 widebody aircraft.</li>    <li>Once all orders are delivered, American will operate 89 787s.</li>    <li>AAL will also defer delivery of 40 737 MAX aircraft scheduled to arrive between 2020 and 2022.</li>    <li>&ldquo;This was a difficult decision between the Boeing 787 and the Airbus A350 and A330neo and we thank both manufacturers for their aggressive efforts to earn more of American&rsquo;s business,\" said AAL President Robert Isom. \"In the end, our goal to simplify our fleet made the 787 a more compelling choice.&rdquo;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3341402-boeing-nears-widebody-jet-order-american-airbus-ends-talks\" target=\"_blank\">Boeing nears widebody jet order from American after Airbus ends talks</a> (Mar. 23 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344273\" data-linked=\"American Airlines orders 47 new Boeings, ending Airbus order\" data-tweet=\"$AAL $AAL $BA - American Airlines orders 47 new Boeings, ending Airbus order https://seekingalpha.com/news/3344273-american-airlines-orders-47-new-boeings-ending-airbus-order?source=tweet\" data-url=\"https://seekingalpha.com/news/3344273-american-airlines-orders-47-new-boeings-ending-airbus-order\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344266\" data-ts=\"1523050497\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIFS\" target=\"_blank\">CIFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344266-after-hours-gainers-losers-04-06-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (04/06/2018)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='green'>+2.6%</font>. <a href='https://seekingalpha.com/symbol/BPT' title='BP Prudhoe Bay Royalty Trust'>BPT</a> <font color='green'>+2.4%</font>. <a href='https://seekingalpha.com/symbol/VEON' title='VEON Ltd. ADS'>VEON</a>&nbsp;<font color='green'>+1.4%</font>. <a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation PLC'>AMRN</a>&nbsp;<font color='green'>+1.4%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/BRFS' title='BRF-Brasil Foods S.A.'>BRFS</a> <font color='red'>-2.2%</font>. <a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a> <font color='red'>-2.1%</font>. <a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a>&nbsp;<font color='red'>-1.4%.</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3344266\" data-linked=\"After Hours Gainers / Losers (04/06/2018)\" data-tweet=\"$CIFS $CIFS $BPT - After Hours Gainers / Losers (04/06/2018) https://seekingalpha.com/news/3344266-after-hours-gainers-losers-04-06-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344266-after-hours-gainers-losers-04-06-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344260\" data-ts=\"1523048053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AQB\" target=\"_blank\">AQB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344260-aquabounty-registers-100m-mixed-shelf-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AquaBounty registers $100M mixed shelf offering</a></h4><ul><li>AquaBounty Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AQB' title='AquaBounty Technologies, Inc.'>AQB</a>) files a <a href=\"https://www.sec.gov/Archives/edgar/data/1603978/000160397818000031/s-3registrationstatement.htm\" target=\"_blank\">prospectus </a>for a $100M mixed shelf offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344260\" data-linked=\"AquaBounty registers $100M mixed shelf offering\" data-tweet=\"$AQB - AquaBounty registers $100M mixed shelf offering https://seekingalpha.com/news/3344260-aquabounty-registers-100m-mixed-shelf-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3344260-aquabounty-registers-100m-mixed-shelf-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344247\" data-ts=\"1523045513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLY\" target=\"_blank\">NLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344247-working-today-mortgage-reits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Working today? The mortgage REITs</a></h4><ul><li>Today's dive in stocks was about as broad as it gets, with even defensive income favorites like utilities and equity REITs in the red (though not nearly as much as the major averages).</li><li>Many of the mortgage REITs (BATS:<a href='https://seekingalpha.com/symbol/REM' title='iShares Mortgage Real Estate Capped ETF'>REM</a>), however, were positive on the session, sector giants Annaly Capital (<a href='https://seekingalpha.com/symbol/NLY' title='Annaly Capital Management, Inc.'>NLY</a> <font color='green'>+0.5%</font>), and AGNC Investment (<a href='https://seekingalpha.com/symbol/AGNC' title='AGNC Investment Corp.'>AGNC</a> <font color='green'>+0.5%</font>) among them. Also higher: CYS Investments (<a href='https://seekingalpha.com/symbol/CYS' title='CYS Investments, Inc.'>CYS</a> <font color='green'>+0.7%</font>), Armour Residential (<a href='https://seekingalpha.com/symbol/ARR' title='ARMOUR Residential REIT, Inc.'>ARR</a> <font color='green'>+0.3%</font>), New York Mortgage (<a href='https://seekingalpha.com/symbol/NYMT' title='New York Mortgage Trust, Inc.'>NYMT</a>), MFA Financial (<a href='https://seekingalpha.com/symbol/MFA' title='MFA Financial, Inc.'>MFA</a> <font color='green'>+0.2%</font>).</li><li>The 10-year Treasury yield slid six basis points to 2.776%.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/MORL' title='UBS ETRACS Monthly Pay 2x Leveraged Mortgage REIT ETN'>MORL</a>, <a href='https://seekingalpha.com/symbol/REM' title='iShares Mortgage Real Estate Capped ETF'>REM</a>, <a href='https://seekingalpha.com/symbol/MORT' title='VanEck Vectors Mortgage REIT Income ETF'>MORT</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3344247\" data-linked=\"Working today? The mortgage REITs\" data-tweet=\"$NLY $REM $NLY - Working today? The mortgage REITs https://seekingalpha.com/news/3344247-working-today-mortgage-reits?source=tweet\" data-url=\"https://seekingalpha.com/news/3344247-working-today-mortgage-reits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344240\" data-ts=\"1523044645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTWO\" target=\"_blank\">TTWO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344240-piper-jaffray-sees-fortnite-risk-overblown-for-take-two\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray sees &#39;Fortnite&#39; risk overblown for Take-Two</a></h4><ul>   <li>Take-Two Interactive (<a href=\"http://seekingalpha.com/symbol/TTWO\" target=\"_blank\">TTWO</a> <font color='red'>-3.9%</font>) <a href=\"https://www.cnbc.com/2018/04/06/buy-take-two-because-fortnite-risk-is-overblown-analyst-says.html\" target=\"_blank\">needn't worry</a> about the rampaging popularity of battle-royale game <i>Fortnite</i> and its effect on Take-Two's cash cow <i>Grand Theft Auto,</i> Piper Jaffray says.</li>    <li>The user base on <i>Fortnite</i> is 13-14 years old, while <i>GTA</i> players are much older on average, analyst Michael Olson says.</li>    <li><i>Fortnite's</i> popularity since Epic Games added a free-to-play battle royale mode in September has been a major catalyst in discussion of videogame stocks. It's now the top-viewed game on Twitch and most widely played on Xbox, Tae Kim notes.</li>    <li><a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a> is <font color='red'>down 10.2%</font> YTD.</li>    <li>Olson also pointed to a \"significant\" catalyst with the delayed October arrival of <i>Red Dead Redemption 2.</i> He reiterated the firm's Overweight rating on Take-Two and reaffirmed a $127 price target, implying 34% upside from today's lower price.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3340819-jefferies-survival-game-fight-buy-dip-activision\" target=\"_blank\">Jefferies: In survival-game fight, buy dip on Activision</a> (Mar. 21 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3340602-videogame-sales-build-2018-23-percent-february-gains\" target=\"_blank\">Videogame sales build on 2018 with 23% February gains</a> (Mar. 20 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344240\" data-linked=\"Piper Jaffray sees &#39;Fortnite&#39; risk overblown for Take-Two\" data-tweet=\"$TTWO - Piper Jaffray sees &#39;Fortnite&#39; risk overblown for Take-Two https://seekingalpha.com/news/3344240-piper-jaffray-sees-fortnite-risk-overblown-for-take-two?source=tweet\" data-url=\"https://seekingalpha.com/news/3344240-piper-jaffray-sees-fortnite-risk-overblown-for-take-two\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344238\" data-ts=\"1523044376\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBR\" target=\"_blank\">EBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344238-eletrobrasminus-9-brazil-energy-ministry-shakeup-jolts-privatization-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eletrobras -9% as Brazil energy ministry shakeup jolts privatization plan</a></h4><ul>     <li>Eletrobras (<a href='https://seekingalpha.com/symbol/EBR' title='Centrais Eletricas Brasileiras S.A. - Eletrobras'>EBR</a> <font color='red'>-8.9%</font>) tumbles as much as 10% following news of a shakeup at Brazil's Mines and Energy Ministry that could <a href=\"https://www.reuters.com/article/us-brazil-government-energy/eletrobras-shares-plunge-on-shakeup-at-brazil-energy-ministry-idUSKCN1HD2ME\" target=\"_blank\">threaten a government plan to privatize</a> the company.</li>     <li>Paulo Pedrosa, second in charge at the ministry, will leave his post, Reuters reports, adding to upheaval on the day that Minister Fernando Coelho Filho steps down to run for the Congress.</li>     <li>&ldquo;The announcement has a relevant impact on Eletrobras&rsquo; capitalization,\" says an analyst at Itau BBA. \"We believe that this process strongly depends, among other points, on a pro-market name taking over the ministry.&rdquo;</li></ul><div class=\"tiny-share-widget\" data-id=\"3344238\" data-linked=\"Eletrobras -9% as Brazil energy ministry shakeup jolts privatization plan\" data-tweet=\"$EBR - Eletrobras -9% as Brazil energy ministry shakeup jolts privatization plan https://seekingalpha.com/news/3344238-eletrobrasminus-9-brazil-energy-ministry-shakeup-jolts-privatization-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3344238-eletrobrasminus-9-brazil-energy-ministry-shakeup-jolts-privatization-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344235\" data-ts=\"1523043478\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344235-boeing-sinks-again-analyst-touts-robust-aircraft-demand-in-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing sinks again but analyst touts robust aircraft demand in China</a></h4><ul>     <li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='red'>-3.5%</font>) shares have been jolted this week by clashes between the U.S. and China on trade, and today is no different as one of the Dow's two biggest losers (only Caterpillar is worse).</li>     <li>But Baird analyst Peter Arment <a href=\"https://www.barrons.com/articles/plenty-of-runway-left-for-boeing-1523039687\" target=\"_blank\">reiterates BA with an Outperform rating</a>, believing that any punishment China imposes on the U.S. would run against its own interests if it heavily taxed Boeing aircraft, especially as it works to increase its air capacity.</li>     <li>The latest data from the International Air Transport Association shows China's domestic air traffic up 11.8% Y/Y in February, but Arment says China lacks the planes to support such a robust trend.</li><li>&ldquo;China's fleet is only 3,000-plus aircraft vs. 7,000-plus in the U.S.,\"&nbsp;Arment writes, and considering China's population and ballooning middle class, &ldquo;this fleet size remains significantly undersized. Tariff talk creates headline risk to the Boeing stock, but the underlining demand points to significantly higher production requirements over the long-term.&rdquo;</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3344235\" data-linked=\"Boeing sinks again but analyst touts robust aircraft demand in China\" data-tweet=\"$BA - Boeing sinks again but analyst touts robust aircraft demand in China https://seekingalpha.com/news/3344235-boeing-sinks-again-analyst-touts-robust-aircraft-demand-in-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3344235-boeing-sinks-again-analyst-touts-robust-aircraft-demand-in-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344234\" data-ts=\"1523043346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCRX\" target=\"_blank\">PCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344234-pacira-pharma-up-14-on-possible-fda-ok-for-exparel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacira Pharma up 14% on (possible) FDA OK for Exparel</a></h4><ul><li>Pacira Pharmaceuticals (<a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a> <font color='green'>+13.6%</font>) is up on an 8x surge in volume on the (potential) U.S. approval for pain med EXPAREL (bupivacaine liposomal injectable solution) despite a negatively split advisory committee vote in February. Shares were up over 30% before retracing.</li><li>No notices or press releases have been published to corroborate this, however.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331606-fda-ad-com-renders-split-vote-paciras-anesnthesia-med-exparel\" target=\"_blank\">FDA Ad Com renders split vote against Pacira's anesnthesia med Exparel</a> (Feb. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344234\" data-linked=\"Pacira Pharma up 14% on (possible) FDA OK for Exparel\" data-tweet=\"$PCRX - Pacira Pharma up 14% on (possible) FDA OK for Exparel https://seekingalpha.com/news/3344234-pacira-pharma-up-14-on-possible-fda-ok-for-exparel?source=tweet\" data-url=\"https://seekingalpha.com/news/3344234-pacira-pharma-up-14-on-possible-fda-ok-for-exparel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344232\" data-ts=\"1523041942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLNK\" target=\"_blank\">NLNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344232-newlinkminus-44-sets-review-of-clinical-programs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NewLink -44%; sets review of clinical programs</a></h4><ul><li>The announcement this morning of the failure of Incyte's and Merck's ECHO-301 trial for patients with advanced melanoma is a blow for the IDO field, says the company.</li><li>While NewLink's (<a href='https://seekingalpha.com/symbol/NLNK' title='NewLink Genetics Corporation'>NLNK</a> <font color='red'>-44.3%</font>) IDO pathway inhibitor has a differentiated mechanism of action which still might demonstrate clinical benefit, the company is nevertheless reviewing programs and will update when complete.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17122814-b-newlink-b-genetics-announces-review-clinical-programs\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3344121-incytes-late-stage-epacadostat-flop-pressures-newlink-genetics-32-percent-premarket\" target=\"_blank\">Incyte's late-stage epacadostat flop pressures NewLink Genetics, down 32% premarket</a> (April 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344232\" data-linked=\"NewLink -44%; sets review of clinical programs\" data-tweet=\"$NLNK - NewLink -44%; sets review of clinical programs https://seekingalpha.com/news/3344232-newlinkminus-44-sets-review-of-clinical-programs?source=tweet\" data-url=\"https://seekingalpha.com/news/3344232-newlinkminus-44-sets-review-of-clinical-programs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344231\" data-ts=\"1523041828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPL\" target=\"_blank\">BPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344231-buckeye-partners-asks-to-move-laurel-pipeline-fuels-in-two-directions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buckeye Partners asks to move Laurel pipeline fuels in two directions</a></h4><ul>     <li>Buckeye Partners (<a href='https://seekingalpha.com/symbol/BPL' title='Buckeye Partners L.P.'>BPL</a> <font color='red'>-2.8%</font>) says it is taking steps to <a href=\"https://finance.yahoo.com/news/laurel-pipeline-operator-wants-move-145114464.html\" target=\"_blank\">move refined fuels in two directions</a> on a portion of its Laurel pipeline while it asks Pennsylvania regulators to allow it to reverse the flow from west to east.</li>     <li>BPL says it wants to make service bi-directional along the Altoona-to-Pittsburgh section of the 350-mile pipeline to enable it to bring fuels from Midwest refiners to customers farther east in Pennsylvania.</li>     <li>An administrative law judge recently recommended the state's Public Utility Commission <a href=\"https://seekingalpha.com/news/3342665-pennsylvania-regulator-recommends-reversal-buckeyes-laurel-pipeline\" target=\"_blank\">reject BPL's application</a> to reverse the flow.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344231\" data-linked=\"Buckeye Partners asks to move Laurel pipeline fuels in two directions\" data-tweet=\"$BPL - Buckeye Partners asks to move Laurel pipeline fuels in two directions https://seekingalpha.com/news/3344231-buckeye-partners-asks-to-move-laurel-pipeline-fuels-in-two-directions?source=tweet\" data-url=\"https://seekingalpha.com/news/3344231-buckeye-partners-asks-to-move-laurel-pipeline-fuels-in-two-directions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344227\" data-ts=\"1523041219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LFIN\" target=\"_blank\">LFIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344227-technology-top-5-gainers-losers-of-3-00-pm-04-06-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 PM (04/06/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='green'>+47%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='green'>+8%</font>. TI-A <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/TI' title='Telecom Italia S.P.A.'>TI</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/TNTR-OLD' title='Tintri, Inc.'>TNTR-OLD</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NETE' title='Net Element International, Inc.'>NETE</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/RUN' title='Sunrun'>RUN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/LUNA' title='Luna Innovations Incorporated'>LUNA</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/ITI' title='Iteris, Inc'>ITI</a> <font color='red'>-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344227\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 PM (04/06/2018)\" data-tweet=\"$LFIN $LFIN $NIHD - Technology - Top 5 Gainers / Losers as of 3:00 PM (04/06/2018) https://seekingalpha.com/news/3344227-technology-top-5-gainers-losers-of-3-00-pm-04-06-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344227-technology-top-5-gainers-losers-of-3-00-pm-04-06-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344228\" data-ts=\"1523041199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABB\" target=\"_blank\">ABB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344228-abb-hopes-for-u-s-concessions-for-tariffs-on-chinese-special-steel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ABB hopes for U.S. concessions for tariffs on Chinese special steel</a></h4><ul>     <li>ABB Ltd. (<a href='https://seekingalpha.com/symbol/ABB' title='ABB LTD.'>ABB</a> <font color='red'>-2.2%</font>) hopes the U.S. government <a href=\"https://www.reuters.com/article/us-usa-trade-china-abb/abb-hopes-for-u-s-concessions-on-tariffs-on-chinese-special-steel-idUSKCN1HD1QU\" target=\"_blank\">will make some concessions</a> on its plan to slap tariffs on steel imports from China, and is \"in discussions with the [U.S.] government on how to deal with this special situation,\" CEO Ulrich Spiesshofer tells Reuters.</li>     <li>ABB operates more than 60 production sites in the U.S., and it needs special steel of a certain quality that is not available in the required amount in the U.S. for its local production of certain transformers and electric engines, Spiesshofer says.</li>          <li>Asked why he expected the U.S. government to support a Swiss company, the CEO says &ldquo;We are one of the largest copper and steel buyers in the world, we buy very, very much, and that is why we are listened to.&rdquo;</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344228\" data-linked=\"ABB hopes for U.S. concessions for tariffs on Chinese special steel\" data-tweet=\"$ABB - ABB hopes for U.S. concessions for tariffs on Chinese special steel https://seekingalpha.com/news/3344228-abb-hopes-for-u-s-concessions-for-tariffs-on-chinese-special-steel?source=tweet\" data-url=\"https://seekingalpha.com/news/3344228-abb-hopes-for-u-s-concessions-for-tariffs-on-chinese-special-steel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344226\" data-ts=\"1523040506\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRZO\" target=\"_blank\">CRZO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344226-carrizo-oil-says-agrees-p-e-firm-assets-undervalued\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carrizo Oil says it agrees with P-E firm that assets undervalued</a></h4><ul>     <li>Carrizo Oil &amp; Gas (<a href='https://seekingalpha.com/symbol/CRZO' title='Carrizo Oil & Gas, Inc.'>CRZO</a> <font color='red'>-6.4%</font>) says it agrees with Kimmeridge Energy Management that its <a href=\"https://seekingalpha.com/pr/17122292-carrizo-oil-and-gas-responds-kimmeridge-13d-filing\" target=\"_blank\">assets are undervalued</a> compared with peer companies with similar quality properties but adds it will only pursue potential deals if \"it deems them to be accretive to, and in the best interest of, all shareholders.\"</li>     <li>CRZO says it has held ongoing discussions with Kimmeridge since the P-E firm acquired a material stake in the company&rsquo;s stock in late 2017, but it believes executing on its development programs in the Eagle Ford Shale and the Delaaware Basin will \"reduce the current discount\" in its shares.</li>     <li>Kimmeridge now owns or controls ~8.1% of CRZO shares and now is the company&rsquo;s fourth-largest shareholder, after previously holding a ~4.9% stake.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344226\" data-linked=\"Carrizo Oil says it agrees with P-E firm that assets undervalued\" data-tweet=\"$CRZO - Carrizo Oil says it agrees with P-E firm that assets undervalued https://seekingalpha.com/news/3344226-carrizo-oil-says-agrees-p-e-firm-assets-undervalued?source=tweet\" data-url=\"https://seekingalpha.com/news/3344226-carrizo-oil-says-agrees-p-e-firm-assets-undervalued\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344224\" data-ts=\"1523039948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OGEN\" target=\"_blank\">OGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344224-oragenics-prices-900k-share-placement-gains-down-to-23\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oragenics prices 900K-share placement; gains down to 23%</a></h4><ul>   <li>Oragenics (<a href=\"http://seekingalpha.com/symbol/OGEN\" target=\"_blank\">OGEN</a> <font color='green'>+22.6%</font>) has pared gains that hit as much as 64% today after <a href=\"https://seekingalpha.com/pr/17122797-oragenics-inc-announces-pricing-1_8-million-registered-direct-offering\" target=\"_blank\">pricing a registered direct offering</a> of 900,000 shares.</li>    <li>The company has an agreement with new institutional investors for the purchase and sale of that amount of common stock at $2/share. <a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> is currently back down to $2.33, still a 23% gain on the day.</li>    <li>Gross proceeds are about $1.8M. It's also issuing unregistered warrants to the investors to purchase up to an equivalent number of shares of common stock with a $2/share exercise price, exercisable six months from the closing date (expected on Tuesday).</li>    <li>Ladenburg Thalmann is the exclusive placement agent.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344160-oragenics-bucks-markets-sour-mood-38-percent\" target=\"_blank\">Oragenics bucks market's sour mood, up 38%</a> (Apr. 06 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344224\" data-linked=\"Oragenics prices 900K-share placement; gains down to 23%\" data-tweet=\"$OGEN - Oragenics prices 900K-share placement; gains down to 23% https://seekingalpha.com/news/3344224-oragenics-prices-900k-share-placement-gains-down-to-23?source=tweet\" data-url=\"https://seekingalpha.com/news/3344224-oragenics-prices-900k-share-placement-gains-down-to-23\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344200\" data-ts=\"1523039411\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNC\" target=\"_blank\">PNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344200-sec-fines-pnc-among-brokerages\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SEC fines PNC among other brokerages</a></h4><ul><li><a href=\"https://www.marketwatch.com/story/sec-fines-pnc-ameriprise-units-for-investment-advisor-conflicts-2018-04-06\" target=\"_blank\">The SEC settles with</a>&nbsp;PNC Investments (<a href='https://seekingalpha.com/symbol/PNC' title='PNC Financial Services Group, Inc.'>PNC</a> <font color='red'>-3.8%</font>) and other brokerages, including Securities America Advisors and Geneos Wealth, who the agency said failed to disclose conflict of interest in their sales practices leading to a breach of their fiduciary duty to clients.</li><li>The firms generated upwards of $12M in improper fees, the SEC&nbsp;says, when they invested advisory clients in higher-cost mutual fund shares when lower-cost shares of the same funds were available.</li><li>The securities houses will pay $15M in fines without admitting to or denying the allegations, and will return more than $12M to affected clients.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344200\" data-linked=\"SEC fines PNC among other brokerages\" data-tweet=\"$PNC - SEC fines PNC among other brokerages https://seekingalpha.com/news/3344200-sec-fines-pnc-among-brokerages?source=tweet\" data-url=\"https://seekingalpha.com/news/3344200-sec-fines-pnc-among-brokerages\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344222\" data-ts=\"1523038951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NMKEF\" target=\"_blank\">NMKEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344222-softbank-acquires-stake-in-canadas-nemaska-lithium\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SoftBank acquires stake in Canada&#39;s Nemaska Lithium</a></h4><ul>     <li>Nemaska Lithium (<a href='https://seekingalpha.com/symbol/NMKEF' title='Nemaska Lithium, Inc.'>OTCQX:NMKEF</a> <font color='green'>+12.4%</font>) surges after SoftBank <a href=\"https://www.reuters.com/article/us-nemaska-lithium-softbank-group/softbank-to-buy-up-to-9-9-percent-stake-in-canadas-nemaska-lithium-idUSKCN1HD0CT\" target=\"_blank\">agrees to acquire a 9.9% stake</a> in the Canadian company and invest as much as C$99M (US$77.M) through a private placement.</li>     <li>The investment, which SoftBank says is its first in the lithium industry, will be made through a private placement of share subscription receipts at C$1.12 each.</li>     <li>Nemaska is <a href=\"http://www.energy-business-review.com/news/softbank-group-to-acquire-stake-in-canadas-nemaska-lithium-060418-6106365\" target=\"_blank\">developing</a> the Whabouchi mine in Quebec, one of the richest spodumene hard rock lithium deposits in the world, and is building a lithium electrochemical plant (refining plant) at Shawinigan, which is expected to start commercial production of lithium hydroxide and lithium carbonate in 2020.</li>     <li>Nemaska also is in talks with U.S. P-E firm Orion Mine Finance Group about a <a href=\"https://www.reuters.com/article/nemaska-lithium-streaming/canadas-nemaska-orion-in-talks-on-lithium-stream-deal-sources-idUSL2N1RI080\" target=\"_blank\">possible lithium streaming deal</a>, Reuters reports.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344222\" data-linked=\"SoftBank acquires stake in Canada&#39;s Nemaska Lithium\" data-tweet=\"$NMKEF - SoftBank acquires stake in Canada&#39;s Nemaska Lithium https://seekingalpha.com/news/3344222-softbank-acquires-stake-in-canadas-nemaska-lithium?source=tweet\" data-url=\"https://seekingalpha.com/news/3344222-softbank-acquires-stake-in-canadas-nemaska-lithium\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344216\" data-ts=\"1523038705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JPM\" target=\"_blank\">JPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344216-jpmorgan-sued-libyan-investment-fund\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan sued by Libyan investment fund</a></h4><ul><li>The&nbsp;Libyan Investment Authority, a sovereign wealth fund set up by former dictator Moammar Qaddafi,<a href=\"https://www.bloomberg.com/news/articles/2018-04-06/jpmorgan-faces-lawsuit-from-qaddafi-s-libyan-investment-fund\" target=\"_blank\">&nbsp;filed a lawsuit against&nbsp;JPMorgan&nbsp;</a>(<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color='red'>-2.9%</font>) in a London court&nbsp;as a &ldquo;commercial fraud&rdquo; claim.</li><li>This comes on the heels of a $1.2B settlement of a lawsuit by SocGen, in which the French bank was accused of bribing businessman&nbsp;Walid Al-Giahmi to win business from the Libyan fund.</li><li>More banks may see the fund in court as Libyans say&nbsp;Giahmi may have acted &ldquo;in the same way&rdquo; on five sets of transactions involving other lenders.</li><li>A JPMorgan spokesperson declined to comment on the matter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344216\" data-linked=\"JPMorgan sued by Libyan investment fund\" data-tweet=\"$JPM - JPMorgan sued by Libyan investment fund https://seekingalpha.com/news/3344216-jpmorgan-sued-libyan-investment-fund?source=tweet\" data-url=\"https://seekingalpha.com/news/3344216-jpmorgan-sued-libyan-investment-fund\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344221\" data-ts=\"1523038161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344221-s-and-p-500-down-2-decline-deepens\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">S&amp;P 500 down 2% as decline deepens</a></h4><ul><li>The customary bounce attempt has failed, with the S&amp;P 500 and Nasdaq now&nbsp;<font color='red'>down 2%</font>&nbsp;two hours before the close. The Dow is&nbsp;<font color='red'>down 2.4%</font>.</li><li>At 2,608, the S&amp;P 500 is right around the level of its panicky early February low - what technicians might call support.</li><li>Faring worst today are the industrials (<a href='https://seekingalpha.com/symbol/XLI' title='Industrial Select Sector SPDR ETF'>XLI</a> <font color='red'>-2.8%</font>) and the financials (<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='red'>-2.8%</font>).</li><li>Working best are income plays like utilities (<a href='https://seekingalpha.com/symbol/XLU' title='Utilities Select Sector SPDR ETF'>XLU</a> <font color='red'>-0.6%</font>) and REITs (<a href='https://seekingalpha.com/symbol/IYR' title='iShares U.S. Real Estate ETF'>IYR</a> <font color='red'>-0.7%</font>) as the 10-year Treasury yield dips nearly five basis points to 2.785%.</li><li><strong>Updated at 3 ET:</strong> The Dow is now&nbsp;<font color='red'>lower by a full 3%</font>, and the S&amp;P 500 and Nasdaq&nbsp;<font color='red'>by 2.6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344221\" data-linked=\"S&amp;P 500 down 2% as decline deepens\" data-tweet=\"$XLI $XLF $XLU - S&amp;P 500 down 2% as decline deepens https://seekingalpha.com/news/3344221-s-and-p-500-down-2-decline-deepens?source=tweet\" data-url=\"https://seekingalpha.com/news/3344221-s-and-p-500-down-2-decline-deepens\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>90&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344220\" data-ts=\"1523037910\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVU\" target=\"_blank\">SVU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344220-supervalu-shoots-up-on-sale-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Supervalu shoots up on sale report</a></h4><ul><li>Supervalu (<a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a> <font color='green'>+6.2%</font>) spikes off reports that the company is working with advisers on a potential sale.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344220\" data-linked=\"Supervalu shoots up on sale report\" data-tweet=\"$SVU - Supervalu shoots up on sale report https://seekingalpha.com/news/3344220-supervalu-shoots-up-on-sale-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3344220-supervalu-shoots-up-on-sale-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344218\" data-ts=\"1523037627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBII\" target=\"_blank\">MBII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344218-energy-materials-top-gainers-losers-of-2-00-pm-04-06-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm (04/06/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MBII' title='Marrone Bio Innovations, Inc.'>MBII</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/MVO' title='MV Oil Trust'>MVO</a> <font color='green'>+9%.</font></li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/HK' title='Halcon Resources Corporation'>HK</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344218\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm (04/06/2018)\" data-tweet=\"$MBII $MBII $MVO - Energy/Materials - Top Gainers / Losers as of 2:00 pm (04/06/2018) https://seekingalpha.com/news/3344218-energy-materials-top-gainers-losers-of-2-00-pm-04-06-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344218-energy-materials-top-gainers-losers-of-2-00-pm-04-06-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344212\" data-ts=\"1523034909\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HEAR\" target=\"_blank\">HEAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344212-turtle-beach-announces-stock-split\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Turtle Beach announces stock split</a></h4><ul> <li>Turtle Beach (<a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a> <font color='red'>-6.1%</font>) announces&nbsp;a 1-for-4 reverse split of its common stock.</li><li>The split, which is effective as of today's close,&nbsp;will reduce the number of outstanding shares from ~49.4M to ~12.4M.</li><li>Turtle Beach's trading symbol will remain HEAR.</li> <li>\"Today's reverse stock split will enable Turtle Beach to regain compliance with NASDAQ's continued listing standards regarding bid price and allow us to remain focused on furthering our position as the leader in console gaming headsets,\" says CEO&nbsp;Juergen Stark</li><li>Source: <a href=\"https://seekingalpha.com/pr/17122746-turtle-beach-announces-1minus-4-reverse-stock-split\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3344212\" data-linked=\"Turtle Beach announces stock split\" data-tweet=\"$HEAR - Turtle Beach announces stock split https://seekingalpha.com/news/3344212-turtle-beach-announces-stock-split?source=tweet\" data-url=\"https://seekingalpha.com/news/3344212-turtle-beach-announces-stock-split\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344211\" data-ts=\"1523034736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLVS\" target=\"_blank\">CLVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344211-clovis-oncologyplus-3_8-on-approved-expansion-for-rubraca\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clovis Oncology +3.8% on approved expansion for Rubraca</a></h4><ul>   <li>Clovis Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a>) is <font color='green'>up 3.8%</font> as the FDA has given it <a href=\"https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=209115\" target=\"_blank\">expanded approval</a> for its lead drug in ovarian cancer.</li>    <li>Rubraca has won an label expansion for second-line or later maintenance treatment in patients with the cancer.</li>    <li>It competes in a growing market of PARP inhibitors with Lynparza from AstraZeneca (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color='green'>+0.5%</font>), and with Zejula, from Tesaro (NASDAQ:<a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344211\" data-linked=\"Clovis Oncology +3.8% on approved expansion for Rubraca\" data-tweet=\"$CLVS $CLVS $AZN - Clovis Oncology +3.8% on approved expansion for Rubraca https://seekingalpha.com/news/3344211-clovis-oncologyplus-3_8-on-approved-expansion-for-rubraca?source=tweet\" data-url=\"https://seekingalpha.com/news/3344211-clovis-oncologyplus-3_8-on-approved-expansion-for-rubraca\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344208\" data-ts=\"1523034039\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIFS\" target=\"_blank\">CIFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344208-financials-top-gainers-losers-of-1-00-pm-04-06-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (04/06/2018)</a></h4><ul><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='red'>-12%.</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3344208\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (04/06/2018)\" data-tweet=\"$CIFS - Financials - Top Gainers / Losers as of 1:00 PM (04/06/2018) https://seekingalpha.com/news/3344208-financials-top-gainers-losers-of-1-00-pm-04-06-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344208-financials-top-gainers-losers-of-1-00-pm-04-06-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344206\" data-ts=\"1523033807\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIFS\" target=\"_blank\">CIFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344206-china-internet-slides-double-digits-muddy-waters-still-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Internet slides double digits with Muddy Waters &#39;still short&#39;</a></h4><ul>   <li>China Internet Nationwide Financial Services (<a href=\"http://seekingalpha.com/symbol/CIFS\" target=\"_blank\">CIFS</a> <font color='red'>-13.3%</font>) is hitting a session low after Muddy Waters Research tweets \"<a href=\"https://twitter.com/muddywatersre/status/982297594083753985\" target=\"_blank\">we're still short</a>.\"</li>    <li>The firm is a \"King Zero -- just another <a href=\"http://www.muddywatersresearch.com/research/cifs/mw-is-short-china-internet-financial-services/\" target=\"_blank\">worthless China fraud</a>,\" the short seller says in a report.</li>    <li>None of the company's purported business is real, Muddy Waters says, noting PRC financials show CIFS overstated 2016 revenue by a multiple of five.</li>    <li>The company's loans look like they're made to sham counterparties, the firm says, and even disclosed business with two related parties look like they're for fraudulent loans.</li>    <li>In a <a href=\"https://twitter.com/muddywatersre/status/982297407856689153\" target=\"_blank\">new tweet</a>, Muddy Water links it to Longfin (<a href=\"http://seekingalpha.com/symbol/LFIN\" target=\"_blank\">LFIN</a> <font color='green'>+47.3%</font>), noting the two share Network 1 Financial Securities as an underwriter (lead for Longfin, co-lead for CIFS).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344206\" data-linked=\"China Internet slides double digits with Muddy Waters &#39;still short&#39;\" data-tweet=\"$CIFS $CIFS $LFIN - China Internet slides double digits with Muddy Waters &#39;still short&#39; https://seekingalpha.com/news/3344206-china-internet-slides-double-digits-muddy-waters-still-short?source=tweet\" data-url=\"https://seekingalpha.com/news/3344206-china-internet-slides-double-digits-muddy-waters-still-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344204\" data-ts=\"1523033093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344204-wynn-denies-sale-talks-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wynn denies sale talks - Bloomberg</a></h4><ul><li>A Wynn (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) spokesman tells Bloomberg the company hasn't held sales talks with MGM Grand (NYSE:<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a>).</li><li>Shares are&nbsp;<font color='red'>down 0.8%</font>&nbsp;on the session after being up more than 2% premarket on report of MGM's interest.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344079-mgm-said-approached-wynn-resorts\" target=\"_blank\">MGM said to have approached Wynn Resorts</a> (April 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344204\" data-linked=\"Wynn denies sale talks - Bloomberg\" data-tweet=\"$WYNN $WYNN $MGM - Wynn denies sale talks - Bloomberg https://seekingalpha.com/news/3344204-wynn-denies-sale-talks-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3344204-wynn-denies-sale-talks-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344203\" data-ts=\"1523032651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AA\" target=\"_blank\">AA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344203-aluminum-prices-surge-traders-surprised-new-u-s-sanctions-on-russia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aluminum prices surge as traders surprised by new U.S. sanctions on Russia</a></h4><ul>     <li><a href=\"https://www.ft.com/content/f95357c6-39b2-11e8-8eee-e06bde01c544\" target=\"_blank\">Aluminum prices surge</a>, as traders are surprised by the U.S. decision to <a href=\"https://seekingalpha.com/news/3344186-gazprom-ceo-rusal-among-targets-new-u-s-sanctions-russia\" target=\"_blank\">slap new tariffs on Russian businesses and individuals</a>, including aluminum producer Rusal and billionaire CEO Oleg Deripaska.</li>     <li>LME aluminum prices jumped 2% to $2,046.50/metric ton and the premium to allow for immediate delivery of metal from warehouses in the U.S. surged 3% to $0.18/lb., its highest level since the futures contract was launched on the CME in 2013.</li>     <li>Russia is the second largest supplier of aluminum to the U.S. after Canada, and Rusal is responsible for 7% of global aluminum production; analysts and traders say the new tariffs likely will lead to more aluminum reaching the U.S. from Australia and Europe.</li>     <li><a href=\"https://www.cnbc.com/2018/04/06/trump-touts-falling-aluminum-prices-as-reason-to-not-fear-tariffs.html\" target=\"_blank\">Pres. Trump tweeted today</a> that falling aluminum prices are a sign that his tariffs are not hurting the economy, but the price of Midwest premium aluminum has more than doubled this year and is still near YTD highs.</li>     <li>Among potentially relevant tickers: <a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color='green'>+1.8%</font>, <a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a> <font color='green'>+0.6%</font>, <a href='https://seekingalpha.com/symbol/KALU' title='Kaiser Aluminum Corporation'>KALU</a> <font color='red'>-1.5%</font>.</li>     <li>ETFs: <a href='https://seekingalpha.com/symbol/JJU-OLD' title='iPath Dow Jones-UBS Aluminum Total Return Sub-IndexS ETN'>JJU-OLD</a>, <a href='https://seekingalpha.com/symbol/FOIL' title='iPath Pure Beta Aluminum ETN'>FOIL</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3344203\" data-linked=\"Aluminum prices surge as traders surprised by new U.S. sanctions on Russia\" data-tweet=\"$AA $AA $CENX - Aluminum prices surge as traders surprised by new U.S. sanctions on Russia https://seekingalpha.com/news/3344203-aluminum-prices-surge-traders-surprised-new-u-s-sanctions-on-russia?source=tweet\" data-url=\"https://seekingalpha.com/news/3344203-aluminum-prices-surge-traders-surprised-new-u-s-sanctions-on-russia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344197\" data-ts=\"1523032628\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBX\" target=\"_blank\">GBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344197-greenbrier-down-2-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Greenbrier down 2% post Q2 results</a></h4><ul><li>The Greenbrier (<a href='https://seekingalpha.com/symbol/GBX' title='The Greenbrier Companies, Inc.'>GBX</a> <font color='red'>-2.3%</font>) Q2 revenue increased 11.1% Y/Y to $629.34M due to higher volume of deliveries and higher wheel and components volumes.</li><li>Segment revenue: Manufacturing +13% Y/Y to $511.83M; Wheels &amp; parts +7% Y/Y to $88.71M and Leasing &amp; servicing -32% Y/Y to $28.8M.</li><li>Margins: Gross &ndash;&nbsp;<font color='red'>declined by 426 bps</font>&nbsp;to 16.7% and operating&nbsp;<font color='red'>declined by 472 bps</font>&nbsp;to 9.67%. S&amp;A expense rate<font color='green'> increased by 100 bps</font>&nbsp;to 8%.</li><li>Q2 railcar deliveries <font color='green'>increased 10.2%</font> Q/Q to 4,900 units.</li><li>This quarter company secured orders for 3,400 units globally and had 24,100 units valued at $2.3B in backlog.</li><li>Upgrades FY18 guidance: Deliveries 20,000-22,000 units; revenue $2.4-2.6B; EPS $5 (0.89 tax benefit included).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344081-greenbrier-beats-0_05-beats-revenue\" target=\"_blank\">Greenbrier beats by $0.05, beats on revenue</a> (April 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344197\" data-linked=\"The Greenbrier down 2% post Q2 results\" data-tweet=\"$GBX - The Greenbrier down 2% post Q2 results https://seekingalpha.com/news/3344197-greenbrier-down-2-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3344197-greenbrier-down-2-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344202\" data-ts=\"1523032573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCN\" target=\"_blank\">NVCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344202-midday-gainers-losers-04-06-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (04/06/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a> <font color='green'>+56%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='green'>+47%</font>. <a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/BWEN' title='Broadwind Energy, Inc.'>BWEN</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/CASI' title='CASI Pharmaceuticals'>CASI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/FORD' title='Forward Industries, Inc.'>FORD</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/MBII' title='Marrone Bio Innovations, Inc.'>MBII</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/GEN' title='Genesis Healthcare, Inc.'>GEN</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/TNTR-OLD' title='Tintri, Inc.'>TNTR-OLD</a> <font color='green'>+9%</font>.</li><li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/NLNK' title='NewLink Genetics Corporation'>NLNK</a> <font color='red'>-44%</font>. <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/SNDX' title='Syndax Pharmaceuticals, Inc.'>SNDX</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/ITI' title='Iteris, Inc'>ITI</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/ALNA' title='Allena Pharmaceuticals, Inc.'>ALNA</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/NETE' title='Net Element International, Inc.'>NETE</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/RUN' title='Sunrun'>RUN</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a> <font color='red'>-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344202\" data-linked=\"Midday Gainers / Losers (04/06/2018)\" data-tweet=\"$NVCN $NVCN $LFIN - Midday Gainers / Losers (04/06/2018) https://seekingalpha.com/news/3344202-midday-gainers-losers-04-06-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344202-midday-gainers-losers-04-06-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344201\" data-ts=\"1523032033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344201-amazon-com-fda-in-10-year-spat-over-food-storage-rules\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon.com, FDA in 10-year spat over food-storage rules</a></h4><ul>   <li>Amazon.com (<a href=\"http://seekingalpha.com/symbol/AMZN\" target=\"_blank\">AMZN</a> <font color='red'>-1.6%</font>) has been in a nearly 10-year stalemate with the Food and Drug Administration over an <a href=\"https://www.marketwatch.com/story/amazon-and-the-fda-have-had-a-decade-long-standoff-over-this-kentucky-warehouse-2018-04-06\" target=\"_blank\">unregistered Kentucky warehouse</a> -- a situation that is coming into sharper relief as the retailer makes a bigger move into groceries.</li>    <li>The warehouse in Lexington, Ky., holds snacks, candy, pet food and shelf-stable beverages, and the FDA inspects food storage facilities. But the Amazon warehouse isn't registered with the FDA; the agency says that's a violation of federal law, and Amazon says it believes it doesn't need to register.</li>    <li>Amazon's not making or processing food, notes former FDA associate commissioner Marc Scheineson, but &ldquo;usually when you get a notice of violation letter, you make the changes that are recommended.\"</li>    <li>The FDA sent Amazon a soft warning about the warehouse as far back as July 2008, but the issue may speak to toothlessness of its enforcement mechanisms and too few inspectors in the field.</li>    <li>For its part, Amazon says its sales are retail, and retail shops like grocers don't have to register with the FDA; FDA investigators have replied that the food from that warehouse isn't sold directly to customers and therefore it's a covered food storage facility.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344201\" data-linked=\"Amazon.com, FDA in 10-year spat over food-storage rules\" data-tweet=\"$AMZN - Amazon.com, FDA in 10-year spat over food-storage rules https://seekingalpha.com/news/3344201-amazon-com-fda-in-10-year-spat-over-food-storage-rules?source=tweet\" data-url=\"https://seekingalpha.com/news/3344201-amazon-com-fda-in-10-year-spat-over-food-storage-rules\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344199\" data-ts=\"1523031764\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDR\" target=\"_blank\">MDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344199-mcdermott-cb-and-i-merger-challenged-dissenting-shareholder\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McDermott-CB&amp;I merger challenged by dissenting shareholder</a></h4><ul>     <li>McDermott (<a href='https://seekingalpha.com/symbol/MDR' title='McDermott International, Inc.'>MDR</a> <font color='red'>-5.7%</font>) <a href=\"https://seekingalpha.com/pr/17122543-update-mcdermott-encourages-stockholders-vote-proposed-combination-cb\" target=\"_blank\">urges shareholders</a> to vote for the proposed merger with CB&amp;I&nbsp;(<a href='https://seekingalpha.com/symbol/CBI' title='Chicago Bridge & Iron Company'>CBI</a> <font color='red'>-7.9%</font>) amid <a href=\"https://www.offshoreenergytoday.com/mcdermott-cbi-merger-challenged-by-shareholder/\" target=\"_blank\">objections by one company</a> which owns nearly 2% of MDR shares.</li>     <li>Asset management firm Hotchkis &amp; Wiley yesterday sent a letter to MDR that was critical of the merger and said it planned to vote against the deal as currently structured.</li>     <li>Since the deal was announced, Hotchkis &amp;&nbsp;Wiley says \"CB&amp;I announced troubling results that increase our worry that the business will take longer to fix. The higher risk is also lowering the upside, as the crisis at CB&amp;I is driving the bond market to price McDermott&rsquo;s unsecured notes to finance the deal at over 10%.\"</li><li>In response, MDR says the merger will \"deliver compelling value, make the combined business more competitive  and enable a more consistent, predictable performance through market  cycles.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3344199\" data-linked=\"McDermott-CB&amp;I merger challenged by dissenting shareholder\" data-tweet=\"$MDR $MDR $CBI - McDermott-CB&amp;I merger challenged by dissenting shareholder https://seekingalpha.com/news/3344199-mcdermott-cb-and-i-merger-challenged-dissenting-shareholder?source=tweet\" data-url=\"https://seekingalpha.com/news/3344199-mcdermott-cb-and-i-merger-challenged-dissenting-shareholder\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>120&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344194\" data-ts=\"1523030455\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FORD\" target=\"_blank\">FORD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344194-consumer-top-gainers-losers-of-12-00-pm-04-06-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (04/06/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FORD' title='Forward Industries, Inc.'>FORD</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CELH' title='Celsius Holdings, Inc.'>CELH</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344194\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (04/06/2018)\" data-tweet=\"$FORD $FORD $CELH - Consumer - Top Gainers / Losers as of 12:00 PM (04/06/2018) https://seekingalpha.com/news/3344194-consumer-top-gainers-losers-of-12-00-pm-04-06-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344194-consumer-top-gainers-losers-of-12-00-pm-04-06-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344193\" data-ts=\"1523030390\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMC\" target=\"_blank\">CMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344193-commercial-metals-started-buy-rating-longbow\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Commercial Metals started with Buy rating at Longbow</a></h4><ul>     <li>Commercial Metals (<a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a> <font color='red'>-2.5%</font>) is lower despite initiation of coverage with a <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Longbow+Research+Starts+Commercial+Metals+Company+%28CMC%29+at+Buy/14029450.html\" target=\"_blank\">Buy rating</a> and $27 price target at Longbow Research.</li>     <li>Longbow says its current- and out-year EPS forecasts for CMC are positioned well above Wall Street consensus, \"supported by the incremental strength detected in recent carbon steel channel checks and in-depth analysis of the domestic rebar market (adjusted for implementation of tariffs).\"</li><li>The firm thinks CMC looks uniquely positioned to realize stronger profit growth vs. steel peers over the next 12-24 months due to its leverage to rebar (50%-55% of total company sales) and non-residential construction (70%-75%).</li></ul><div class=\"tiny-share-widget\" data-id=\"3344193\" data-linked=\"Commercial Metals started with Buy rating at Longbow\" data-tweet=\"$CMC - Commercial Metals started with Buy rating at Longbow https://seekingalpha.com/news/3344193-commercial-metals-started-buy-rating-longbow?source=tweet\" data-url=\"https://seekingalpha.com/news/3344193-commercial-metals-started-buy-rating-longbow\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344192\" data-ts=\"1523029603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAT\" target=\"_blank\">CAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344192-soft-commodities-farm-equipment-makers-slump-on-tariff-threat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Soft commodities, farm equipment makers slump on tariff threat</a></h4><ul>     <li>Stocks tumble to session lows after Pres. Trump escalates the tit-for-tat trade battles between the U.S. and China, with soft commodities and farm equipment makers <a href=\"https://www.ft.com/content/9de3f944-39a4-11e8-8b98-2f31af407cc8\" target=\"_blank\">bearing much of the losses</a>; currently, Dow <font color='red'>-1.6%</font>, S&amp;P <font color='red'>-1%</font>, Nasdaq <font color='red'>-0.9%</font>.</li><li>Concerns that China could further target U.S. agricultural farm goods in retaliation cause soybean, corn and live cattle futures to slide ~1%.</li><li>Among stocks related to the agricultural sector, Caterpillar (<a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a> <font color='red'>-3.2%</font>), Deere (<a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a> <font color='red'>-2.4%</font>) and DowDuPont (<a href='https://seekingalpha.com/symbol/DWDP' title='DowDuPont Inc.'>DWDP</a> <font color='red'>-2.1%</font>) are sharply lower, while Monsanto (<a href='https://seekingalpha.com/symbol/MON' title='Monsanto Company'>MON</a> <font color='green'>+0.2%</font>), Archer Daniels Midland (<a href='https://seekingalpha.com/symbol/ADM' title='Archer Daniels Midland Co.'>ADM</a> <font color='red'>-0.2%</font>) and Bunge (<a href='https://seekingalpha.com/symbol/BG' title='Bunge Limited'>BG</a> <font color='green'>+0.4%</font>) are little changed.</li><li>Food producers are mixed, as analysts see tariff action depressing soft commodity prices, thus driving down the cost of inputs for such companies: <a href='https://seekingalpha.com/symbol/TSN' title='Tyson Foods Inc.'>TSN</a> <font color='red'>-0.1%</font>, <a href='https://seekingalpha.com/symbol/HRL' title='Hormel Foods Corporation'>HRL</a> <font color='green'>+0.6%</font>, <a href='https://seekingalpha.com/symbol/PPC' title='Pilgrim&#39;s Pride Corporation'>PPC</a> <font color='red'>-0.2%</font>, <a href='https://seekingalpha.com/symbol/GIS' title='General Mills, Inc.'>GIS</a> <font color='green'>+0.5%</font>, <a href='https://seekingalpha.com/symbol/SAFM' title='Sanderson Farms, Inc.'>SAFM</a> <font color='green'>+0.4%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/DBA' title='Invesco DB Agriculture ETF'>DBA</a>, <a href='https://seekingalpha.com/symbol/CORN' title='Teucrium Corn ETF'>CORN</a>, <a href='https://seekingalpha.com/symbol/WEAT' title='Teucrium Wheat Fund'>WEAT</a>, <a href='https://seekingalpha.com/symbol/SOYB' title='Teucrium Soybean Fund'>SOYB</a>, <a href='https://seekingalpha.com/symbol/JJG' title='iPath Series B Bloomberg Grains Subindex Total Return ETN'>JJG</a>, <a href='https://seekingalpha.com/symbol/RJA' title='ELEMENTS Rogers International Commodity Agriculture ETN'>RJA</a>, <a href='https://seekingalpha.com/symbol/COW' title='iPath DJ-UBS Livestock Total Return Sub-Index ETN'>COW</a>, <a href='https://seekingalpha.com/symbol/DAG' title='DB Agriculture Double Long ETN'>DAG</a>, <a href='https://seekingalpha.com/symbol/JJA' title='iPath DJ-UBS Agriculture Total Return Sub-Index ETN'>JJA</a>, <a href='https://seekingalpha.com/symbol/GRU' title='ELEMENTS MLCX Grains Index Total Return ETN'>GRU</a>, <a href='https://seekingalpha.com/symbol/AGA' title='DB Agriculture Double Short ETN'>OTC:AGA</a>, <a href='https://seekingalpha.com/symbol/WEET' title='iPath Pure Beta Grains ETN'>WEET</a>, <a href='https://seekingalpha.com/symbol/FUD' title='UBS ETRACS CMCI Food Total Return ETN'>FUD</a>, <a href='https://seekingalpha.com/symbol/UAG' title='UBS ETRACS CMCI Agriculture Total Return ETN'>UAG</a>, <a href='https://seekingalpha.com/symbol/USAG' title='The United States Agriculture Index ETF'>USAG</a>, <a href='https://seekingalpha.com/symbol/AGF' title='DB Agriculture Long ETN'>AGF</a>, <a href='https://seekingalpha.com/symbol/TAGS' title='Teucrium Agricultural ETF'>TAGS</a>, <a href='https://seekingalpha.com/symbol/UBC' title='UBS ETRACS CMCI Livestock Total Return ETN'>UBC</a>, <a href='https://seekingalpha.com/symbol/ADZ' title='DB Agriculture Short ETN'>OTC:ADZ</a>, <a href='https://seekingalpha.com/symbol/JJS' title='iPath Dow Jones-UBS Softs Total Return Sub-Index ETN'>JJS</a>, <a href='https://seekingalpha.com/symbol/DIRT' title='iPath Pure Beta Agriculture ETN'>DIRT</a>, <a href='https://seekingalpha.com/symbol/LSTK' title='iPath Pure Beta Livestock ETN'>LSTK</a>, <a href='https://seekingalpha.com/symbol/GRWN' title='iPath Pure Beta Softs ETN'>GRWN</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3344192\" data-linked=\"Soft commodities, farm equipment makers slump on tariff threat\" data-tweet=\"$CAT $CAT $DE - Soft commodities, farm equipment makers slump on tariff threat https://seekingalpha.com/news/3344192-soft-commodities-farm-equipment-makers-slump-on-tariff-threat?source=tweet\" data-url=\"https://seekingalpha.com/news/3344192-soft-commodities-farm-equipment-makers-slump-on-tariff-threat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344191\" data-ts=\"1523029396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBS\" target=\"_blank\">AMBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344191-amarantus-bio-reacquires-rights-to-three-diagnostic-tests-shares-up-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amarantus Bio reacquires rights to three diagnostic tests; shares up 22%</a></h4><ul><li>Amarantus Bioscience Holdings (<a href='https://seekingalpha.com/symbol/AMBS' title='Amarantus Bioscience Holdings, Inc.'>OTCPK:AMBS</a> <font color='green'>+22%</font>) has <a href=\"https://seekingalpha.com/pr/17122693-amarantus-re-acquires-rights-alzheimers-blood-diagnostic-lympro-test\" target=\"_blank\">reacquired </a>the rights to three neurology-focused diagnostic tests, LymPro, MSPrecise and NuroPro, from Avant Diagnostics (<a href='https://seekingalpha.com/symbol/AVDX' title='Avant Diagnostics, Inc.'>OTC:AVDX</a> <font color='red'>-50.7%</font>) in exchange for canceling $722.5K in liabilities and 1M shares of AMBS common stock.</li><li>Avant has also agreed to issue Amarantus an additional ~31.1M Avant shares to satisfy certain amounts owed under the original deal.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344191\" data-linked=\"Amarantus Bio reacquires rights to three diagnostic tests; shares up 22%\" data-tweet=\"$AMBS $AMBS $AVDX - Amarantus Bio reacquires rights to three diagnostic tests; shares up 22% https://seekingalpha.com/news/3344191-amarantus-bio-reacquires-rights-to-three-diagnostic-tests-shares-up-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3344191-amarantus-bio-reacquires-rights-to-three-diagnostic-tests-shares-up-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344190\" data-ts=\"1523028691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSAT\" target=\"_blank\">VSAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344190-viasatminus-1_9-eutelsat-exits-deal-chooses-thales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ViaSat -1.9% as Eutelsat exits deal, chooses Thales</a></h4><ul>   <li>ViaSat (NASDAQ:<a href='https://seekingalpha.com/symbol/VSAT' title='Viasat, Inc.'>VSAT</a>) is <font color='red'>1.9% lower</font> after Eutelsat (<a href=\"http://seekingalpha.com/symbol/EUTLF\" target=\"_blank\">EUTLF</a> <font color='green'>+3.2%</font>) stepped out of a deal to use the ViaSat-3 satellite, choosing instead a local alternative in Thales.</li>    <li>Viasat notes it's <a href=\"https://seekingalpha.com/pr/17122480-viasat-affirms-commitments-bring-powerful-viasatminus-3-satellite-europe\" target=\"_blank\">still \"excited\"</a> about ViaSat-3 for the EMEA region.</li>    <li>With no binding agreement with Eutelsat, the company's capital plan isn't dependent on Eutelsat participating to move forward, ViaSat says.</li><li>And it confirms the decision has no impact on current contracts: \"The current Viasat/Eutelsat joint venture, which has been in operation for more than one year, will continue to be governed under the existing agreements.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344190\" data-linked=\"ViaSat -1.9% as Eutelsat exits deal, chooses Thales\" data-tweet=\"$VSAT $VSAT $EUTLF - ViaSat -1.9% as Eutelsat exits deal, chooses Thales https://seekingalpha.com/news/3344190-viasatminus-1_9-eutelsat-exits-deal-chooses-thales?source=tweet\" data-url=\"https://seekingalpha.com/news/3344190-viasatminus-1_9-eutelsat-exits-deal-chooses-thales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344181\" data-ts=\"1523026850\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OGEN\" target=\"_blank\">OGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344181-healthcare-top-5-gainers-losers-of-11-00-04-06-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/06/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='green'>+41%</font>. <a href='https://seekingalpha.com/symbol/CASI' title='CASI Pharmaceuticals'>CASI</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals'>DOVA</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/GEN' title='Genesis Healthcare, Inc.'>GEN</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NLNK' title='NewLink Genetics Corporation'>NLNK</a> <font color='red'>-38%</font>. <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/SNDX' title='Syndax Pharmaceuticals, Inc.'>SNDX</a> <font color='red'>-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344181\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/06/2018)\" data-tweet=\"$OGEN $OGEN $CASI - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/06/2018) https://seekingalpha.com/news/3344181-healthcare-top-5-gainers-losers-of-11-00-04-06-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344181-healthcare-top-5-gainers-losers-of-11-00-04-06-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344175\" data-ts=\"1523026610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNJN\" target=\"_blank\">FNJN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344175-finjan-slides-18-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finjan slides 18% post Q1 results</a></h4><ul><li>Finjan Holdings (<a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a> <font color='red'>-17.8%</font>) Q1 revenue totaled $65M, an increase of 160% Y/Y.</li><li>Cash was $80.4M; net income from operations was $42.9M (+170% Y/Y).</li><li>The company redeemed &amp; retired all 153,000 Preferred Series A-1 Shares for $19.9M</li><li><a href=\"https://seekingalpha.com/filing/3967791\" target=\"_blank\">Phil Hartstein, President and CEO, stated</a>: \"due to strong balance sheet the company is able to focus on core competency &amp; expertise in monetizing their intellectual property assets, synergistic M&amp;A opportunities &amp; returning cash to shareholders.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3343888-finjan-holdings-beats-0_24-revenue-line\" target=\"_blank\">Finjan Holdings beats by $0.24,  revenue in-line</a> (April 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344175\" data-linked=\"Finjan slides 18% post Q1 results\" data-tweet=\"$FNJN - Finjan slides 18% post Q1 results https://seekingalpha.com/news/3344175-finjan-slides-18-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3344175-finjan-slides-18-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344169\" data-ts=\"1523026134\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGLB\" target=\"_blank\">SGLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344169-sigma-labs-up-2-post-fy17-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sigma Labs up 2% post FY17 results</a></h4><ul><li>Sigma Labs (<a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a> <font color='green'>+1.7%</font>)&nbsp;reported a decrease of 32%Y/Y in the FY17 revenue to $0.64M due to shift in customer base from R&amp;D to more commercialization focused.</li><li>FY gross profit margin&nbsp;<font color='red'>declined by 1819 bps</font>&nbsp;to 57.5%, operating margin&nbsp;<font color='red'>declined by 36698 bps&nbsp;</font>to -632% and net loss was $4.58M.</li><li>FY expenses: Operating +38% Y/Y to $4.42M, R&amp;D +150% Y/Y to $0.30M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344139-sigma-labs-reports-fy-results\" target=\"_blank\">Sigma Labs reports FY results</a> (April 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344169\" data-linked=\"Sigma Labs up 2% post FY17 results\" data-tweet=\"$SGLB - Sigma Labs up 2% post FY17 results https://seekingalpha.com/news/3344169-sigma-labs-up-2-post-fy17-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3344169-sigma-labs-up-2-post-fy17-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344174\" data-ts=\"1523026118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IESC\" target=\"_blank\">IESC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344174-ies-holdings-acquires-azimuth-communications\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IES Holdings acquires Azimuth Communications</a></h4><ul>     <li>IES Holding's (<a href='https://seekingalpha.com/symbol/IESC' title='Integrated Electrical Services, Inc.'>IESC</a> <font color='green'>+0.9%</font>) subsidiary IES Communications <a href=\"https://seekingalpha.com/pr/17122569-ies-holdings-acquires-azimuth-communications\" target=\"_blank\">has acquired</a> Azimuth Communications based in Portland, Oregon. Terms of the transaction were not disclosed.</li>     <li>Robert Lewey, President of IES, said, &ldquo;The acquisition of Azimuth furthers IES Communications&rsquo; growth strategy by significantly accelerating our expansion into the attractive Pacific Northwest market and through the addition of Azimuth&rsquo;s strong team and leading design and integration services.  We are pleased to welcome Azimuth&rsquo;s over 60 team members to IES and are excited to partner with them to continue to grow the combined company.&rdquo;</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344174\" data-linked=\"IES Holdings acquires Azimuth Communications\" data-tweet=\"$IESC - IES Holdings acquires Azimuth Communications https://seekingalpha.com/news/3344174-ies-holdings-acquires-azimuth-communications?source=tweet\" data-url=\"https://seekingalpha.com/news/3344174-ies-holdings-acquires-azimuth-communications\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344168\" data-ts=\"1523025375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLNX\" target=\"_blank\">XLNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344168-xilinxminus-3_7-jpmorgan-cuts-to-underweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xilinx -3.7% as JPMorgan cuts to Underweight</a></h4><ul>   <li>Xilinx (NASDAQ:<a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a>) is <font color='red'>3.7% lower</font> after a downgrade to Underweight by JPMorgan, which sees base station deployments stepping down again in China but mitigated somewhat by 5G deployments elsewhere.</li>    <li>M&amp;A is unlikely for the company, the firm says, and multiple compression is nigh. (h/t Bloomberg)</li>    <li>It's cut its price target to $68 from $73; shares are trading at $68.06 now.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344168\" data-linked=\"Xilinx -3.7% as JPMorgan cuts to Underweight\" data-tweet=\"$XLNX - Xilinx -3.7% as JPMorgan cuts to Underweight https://seekingalpha.com/news/3344168-xilinxminus-3_7-jpmorgan-cuts-to-underweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3344168-xilinxminus-3_7-jpmorgan-cuts-to-underweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344164\" data-ts=\"1523023970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORBC\" target=\"_blank\">ORBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344164-orbcommminus-5_5-after-pricing-3m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orbcomm -5.5% after pricing 3M-share offering</a></h4><ul>   <li>Orbcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/ORBC' title='ORBCOMM Inc.'>ORBC</a>) is <font color='red'>5.5% lower</font> after <a href=\"https://seekingalpha.com/pr/17122606-orbcomm-announces-pricing-public-offering-common-stock\" target=\"_blank\">pricing its 3M-share offering</a> at $8.60 just before the open.</li>    <li>Shares had closed at $9.22 yesterday before the company announced the offering.</li>    <li>Orbcomm is selling all shares and receiving all proceeds; underwriters have a 30-day option to buy up to an additional 450,000 shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344164\" data-linked=\"Orbcomm -5.5% after pricing 3M-share offering\" data-tweet=\"$ORBC - Orbcomm -5.5% after pricing 3M-share offering https://seekingalpha.com/news/3344164-orbcommminus-5_5-after-pricing-3m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3344164-orbcommminus-5_5-after-pricing-3m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344162\" data-ts=\"1523023592\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKZOY\" target=\"_blank\">AKZOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344162-axalta-up-nearly-3-new-deal-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axalta up nearly 3% as new deal chatter</a></h4><ul><li>Talks with Akzo Nobel (<a href='https://seekingalpha.com/symbol/AKZOY' title='Akzo Nobel N.V. ADR'>OTCQX:AKZOY</a>) could be revived, <a href=\"https://www.dealreporter.com/info/\" target=\"_blank\">according to Dealreporter</a>.</li><li><a href='https://seekingalpha.com/symbol/AXTA' title='Axalta Coating Systems'>AXTA</a>&nbsp;<font color='green'>+2.75%</font></li><li>Previously: <a href=\"https://seekingalpha.com/news/3341954-axalta-higher-sale-akzo-nobel-unit\" target=\"_blank\">Axalta higher after sale of Akzo Nobel unit</a> (March 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344162\" data-linked=\"Axalta up nearly 3% as new deal chatter\" data-tweet=\"$AKZOY $AKZOY $AXTA - Axalta up nearly 3% as new deal chatter https://seekingalpha.com/news/3344162-axalta-up-nearly-3-new-deal-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3344162-axalta-up-nearly-3-new-deal-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344160\" data-ts=\"1523023544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OGEN\" target=\"_blank\">OGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344160-oragenics-bucks-markets-sour-mood-up-38\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oragenics bucks market&#39;s sour mood, up 38%</a></h4><ul><li>Thinly traded nano cap Oragenics (<a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='green'>+37.9%</font>) is up in early trade on a healthy 15x surge in volume. Shares have rallied&nbsp;<font color='green'>86%</font>&nbsp;in two days.</li><li>No particular news accounts for the action although a key upcoming event (Q2) is the release of preliminary data from a Phase 2 clinical trial assessing lead candidate AG013 in oral mucositis.</li><li>At the end of December, it had $6.2M in quick assets. Operations consumed $6.4M in 2017 so a capital raise will be needed at some point.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344160\" data-linked=\"Oragenics bucks market&#39;s sour mood, up 38%\" data-tweet=\"$OGEN - Oragenics bucks market&#39;s sour mood, up 38% https://seekingalpha.com/news/3344160-oragenics-bucks-markets-sour-mood-up-38?source=tweet\" data-url=\"https://seekingalpha.com/news/3344160-oragenics-bucks-markets-sour-mood-up-38\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344156\" data-ts=\"1523023428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDFC\" target=\"_blank\">WDFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344156-wdminus-40-company-down-2-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WD-40 Company down 2% post Q2 results</a></h4><ul><li>WD-40 Company (<a href='https://seekingalpha.com/symbol/WDFC' title='WD-40 Company'>WDFC</a> <font color='red'>-2.4%</font>) reports Q2 Revenue of $101.26M (+4.9% Y/Y) where, $92.3M &amp; $8.9M was from Maintenance products &amp; Homecare and cleaning products respectively.</li><li>Gross margin was&nbsp;55.1% Y/Y, operating margin of +19.15% Y/Y &amp; net income of&nbsp;$14.8M (+20% Y/Y)</li><li>FY18 Guidance:&nbsp;Net revenue growth of 7-9%, to $407-415M; gross margin 55%;&nbsp;advertising &amp; promotion investments projected to be near 6% &amp; net income of $56.6-57.5M</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344011-wdminus-40-beats-0_10-misses-revenue\" target=\"_blank\">WD-40 beats by $0.10, misses on revenue</a> (April 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344156\" data-linked=\"WD-40 Company down 2% post Q2 results\" data-tweet=\"$WDFC - WD-40 Company down 2% post Q2 results https://seekingalpha.com/news/3344156-wdminus-40-company-down-2-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3344156-wdminus-40-company-down-2-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344148\" data-ts=\"1523020886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/F\" target=\"_blank\">F</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344148-ford-recalls-350k-trucks-and-suvs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ford recalls 350K trucks and SUVs</a></h4><ul> <li>Ford (NYSE:<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a>) issues a <a href=\"https://www.automotiveworld.com/news-releases/ford-motor-company-issues-two-n-safety-recalls-2/\" target=\"_blank\">recall</a> in North America for ~350K 2018 Ford F-150 and 2018 Ford Expedition vehicles with 10-speed automatic transmissions, as well as 2018 Ford F-650 and F-750 vehicles with 6-speed automatic transmissions.</li> <li>The recall action is to address a potential issue with unseated transmission gear shift cable clips.</li> <li>Shares of Ford are <font color='red'>down 0.79%</font> premarket to $11.26.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3344148\" data-linked=\"Ford recalls 350K trucks and SUVs\" data-tweet=\"$F - Ford recalls 350K trucks and SUVs https://seekingalpha.com/news/3344148-ford-recalls-350k-trucks-and-suvs?source=tweet\" data-url=\"https://seekingalpha.com/news/3344148-ford-recalls-350k-trucks-and-suvs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344146\" data-ts=\"1523020765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LFIN\" target=\"_blank\">LFIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344146-premarket-gainers-of-9-05-04-06-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (04/06/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='green'>+31%</font>.</li><li><a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a> <font color='green'>+6%</font>&nbsp;as <a href=\"https://seekingalpha.com/pr/17122376-ocean-power-technologies-highlight-anchorless-powerbuoy-global-maritime-exposition\" target=\"_blank\">discussion </a>about anchorless PowerBuoy at the Navy Forum for SBIR/STTR Transition in National Harbor,&nbsp;Maryland.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344146\" data-linked=\"Premarket Gainers as of 9:05 am (04/06/2018)\" data-tweet=\"$LFIN $LFIN $OPTT - Premarket Gainers as of 9:05 am (04/06/2018) https://seekingalpha.com/news/3344146-premarket-gainers-of-9-05-04-06-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344146-premarket-gainers-of-9-05-04-06-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344145\" data-ts=\"1523020748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYEG\" target=\"_blank\">EYEG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344145-eyegate-pharma-completes-enrollment-in-late-stage-study-of-egpminus-437-milestone-earned\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EyeGate Pharma completes enrollment in late-stage study of EGP-437, milestone earned; shares up 18% premarket</a></h4><ul><li>Thinly traded nano cap EyeGate Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/EYEG' title='EyeGate Pharmaceuticals'>EYEG</a>) is up&nbsp;<font color='green'>18%&nbsp;</font>premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17122515-eyegate-completes-enrollment-receives-milestone-payment-confirmatory-phase-3-clinical-study\" target=\"_blank\">announcement</a> that it has reached the enrollment target in a<a href=\"https://clinicaltrials.gov/ct2/show/NCT02517619?term=egp-437&amp;rank=1\" target=\"_blank\"> Phase 3 clinical trial</a> assessing lead candidate EGP-437 in non-infectious anterior uveitis. The event triggered an undisclosed milestone payment from exclusive licensee Valeant Pharmaceuticals.</li><li>According to ClinicalTrials.gov, the estimated primary completion date is July.</li><li><a href=\"http://www.eyegatepharma.com/pipeline/egp-437/\" target=\"_blank\">EGP-437</a>&nbsp;is a reformulated topically active corticosteroid, dexamethasone, that is delivered to the eye through the EyeGate II Delivery System.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3318880-eyegate-pharma-earns-milestone-valeant-advancement-late-stage-study-egpminus-437\" target=\"_blank\">EyeGate Pharma earns milestone from Valeant on advancement of late-stage study of EGP-437</a> (Dec. 18, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344145\" data-linked=\"EyeGate Pharma completes enrollment in late-stage study of EGP-437, milestone earned; shares up 18% premarket\" data-tweet=\"$EYEG - EyeGate Pharma completes enrollment in late-stage study of EGP-437, milestone earned; shares up 18% premarket https://seekingalpha.com/news/3344145-eyegate-pharma-completes-enrollment-in-late-stage-study-of-egpminus-437-milestone-earned?source=tweet\" data-url=\"https://seekingalpha.com/news/3344145-eyegate-pharma-completes-enrollment-in-late-stage-study-of-egpminus-437-milestone-earned\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344143\" data-ts=\"1523020511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLNK\" target=\"_blank\">NLNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344143-premarket-losers-of-9-05-4-6-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (4/6/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/NLNK' title='NewLink Genetics Corporation'>NLNK</a>&nbsp;<font color='red'>-40%</font>&nbsp;after disappointing <a href=\"https://seekingalpha.com/news/3344121-incytes-late-stage-epacadostat-flop-pressures-newlink-genetics-32-percent-premarket\" target=\"_blank\">results</a> of a failed late-stage study of IDO1 inhibitor epacadostat.</li><li><a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>&nbsp;<font color='red'>-22%</font>&nbsp;after epacadostat <a href=\"https://seekingalpha.com/news/3344107-incytes-epacadostat-flunks-late-stage-melanoma-study\" target=\"_blank\">flunks</a> late-stage melanoma study.</li><li><a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a>&nbsp;<font color='red'>-18%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3344090-mannkind-prices-28m-private-stock-offering\" target=\"_blank\">pricing</a> direct offering.</li><li><a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a>&nbsp;<font color='red'>-13%</font>&nbsp;after <a href=\"https://seekingalpha.com/news/3344132-northern-oil-minus-13-percent-pricing-58_6m-share-offering-1_50\" target=\"_blank\">pricing</a> 58.6M-share offering at $1.50.</li><li><a href='https://seekingalpha.com/symbol/CDXS' title='Codexis, Inc.'>CDXS</a>&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3344087-codexis-prices-stock-offering-9_25-shares-10-percent-premarket\" target=\"_blank\">pricing</a> stock offering at $9.25.</li><li><a href='https://seekingalpha.com/symbol/NEWM' title='New Media'>NEWM</a>&nbsp;<font color='red'>-8%</font>&nbsp;after share <a href=\"https://seekingalpha.com/news/3344105-new-media-investment-group-10_11-percent-share-pricing\" target=\"_blank\">pricing</a>.</li><li><a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a>&nbsp;<font color='red'>-6%</font>&nbsp;after disappointing&nbsp;<a href=\"https://seekingalpha.com/news/3344130-incyte-epacadostat-flop-weighing-certain-biotechs-premarket\" target=\"_blank\">results</a>&nbsp;of a failed late-stage study of IDO1 inhibitor epacadostat.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3344143\" data-linked=\"Premarket Losers as of 9:05 am (4/6/2018)\" data-tweet=\"$NLNK $NLNK $INCY - Premarket Losers as of 9:05 am (4/6/2018) https://seekingalpha.com/news/3344143-premarket-losers-of-9-05-4-6-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344143-premarket-losers-of-9-05-4-6-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344132\" data-ts=\"1523018966\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOG\" target=\"_blank\">NOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344132-northern-oilminus-13-after-pricing-58_6m-share-offering-1_50\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northern Oil -13% after pricing 58.6M-share offering at $1.50</a></h4><ul>     <li>Northern Oil and Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a>) <font color='red'>-13.3%</font> premarket after saying it <a href=\"https://seekingalpha.com/pr/17122391-northern-oil-gas-inc-announces-pricing-public-offering-common-stock\" target=\"_blank\">priced a public offering</a> of more than 58.6M common shares at $1.50 each, with an underwriters options to purchase up to an additional 8.8M shares.</li><li>NOG says it plans to use the proceeds to       continue to pursue acquisition opportunities, to fund its drilling       program and for general corporate purposes other than debt repayment.</li><li><a href=\"https://seekingalpha.com/news/3343869-northern-oil-gas-minus-7-percent-filing-offer-88m-shares\" target=\"_blank\">Earlier</a>:&nbsp;Northern Oil and Gas -7% after filing to offer $88M in shares (April 5)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344132\" data-linked=\"Northern Oil -13% after pricing 58.6M-share offering at $1.50\" data-tweet=\"$NOG - Northern Oil -13% after pricing 58.6M-share offering at $1.50 https://seekingalpha.com/news/3344132-northern-oilminus-13-after-pricing-58_6m-share-offering-1_50?source=tweet\" data-url=\"https://seekingalpha.com/news/3344132-northern-oilminus-13-after-pricing-58_6m-share-offering-1_50\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344131\" data-ts=\"1523018954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344131-china-warns-of-major-response-on-trade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China warns of  &#39;major response&#39; on trade</a></h4><ul> <li>China's Department of Ministry says it won't hesitate with a \"major\" response to any additional tariffs levied against the nation.</li> <li>It's unclear if anything other than rhetoric will occur before the U.S. Trade Office holds a hearing on its proposed duties on May 15.</li> <li>U.S. stock futures are roughly where they stood before the announcement and the disappointing <a href=\"https://seekingalpha.com/news/3344125-soft-jobs-march-103k-added-ue-rate-holding-4_1-percent\" target=\"_blank\">March U.S. jobs report</a>&nbsp;posted about 20 minutes ago.</li> <li>Dow futures <font color='red'>-0.83%</font>, S&amp;P 500 <font color='red'>-0.73%</font>. Nasdaq 100 <font color='red'>-0.84%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/DIA' title='SPDR Dow Jones Industrial Average ETF'>DIA</a>, <a href='https://seekingalpha.com/symbol/CRF' title='Cornerstone Total Return Fund'>CRF</a>, <a href='https://seekingalpha.com/symbol/USA' title='Liberty All-Star Equity Fund'>USA</a>, <a href='https://seekingalpha.com/symbol/UDOW' title='ProShares UltraPro Dow 30 ETF'>UDOW</a>, <a href='https://seekingalpha.com/symbol/DOG' title='ProShares Short Dow 30 ETF'>DOG</a>, <a href='https://seekingalpha.com/symbol/DXD' title='ProShares UltraShort Dow30 ETF'>DXD</a>, <a href='https://seekingalpha.com/symbol/SDOW' title='ProShares UltraPro Short Dow 30 ETF'>SDOW</a>, <a href='https://seekingalpha.com/symbol/SCHX' title='Schwab U.S. Large-Cap ETF'>SCHX</a>, <a href='https://seekingalpha.com/symbol/ZF' title='Virtus Total Return Fund Inc'>ZF</a>, <a href='https://seekingalpha.com/symbol/DDM' title='ProShares Ultra Dow 30 ETF'>DDM</a>, <a href='https://seekingalpha.com/symbol/VV' title='Vanguard Large Cap ETF'>VV</a>, <a href='https://seekingalpha.com/symbol/FEX' title='First Trust Large Cap Core AlphaDEX ETF'>FEX</a>, <a href='https://seekingalpha.com/symbol/JKD' title='iShares Morningstar Large-Cap ETF'>JKD</a>, <a href='https://seekingalpha.com/symbol/EQL' title='ALPS Equal Sector Weight ETF'>EQL</a>, <a href='https://seekingalpha.com/symbol/EEH' title='ELEMENTS SPECTRUM Large Cap U.S. Sector ETN'>EEH</a>, <a href='https://seekingalpha.com/symbol/IWL' title='iShares Russell Top 200 ETF'>IWL</a>, <a href='https://seekingalpha.com/symbol/FWDD' title='AdvisorShares Madrona Domestic ETF'>FWDD</a>, <a href='https://seekingalpha.com/symbol/EDOW' title='First Trust Dow 30 Equal Weight ETF'>EDOW</a>, <a href='https://seekingalpha.com/symbol/SYE' title='SPDR MFS Systematic Core Equity ETF'>SYE</a>, <a href='https://seekingalpha.com/symbol/JHML' title='John Hancock Multifactor Large Cap ETF'>JHML</a>, <a href='https://seekingalpha.com/symbol/UDPIX' title='ProFunds Ultra Dow 30 ProFund Inv'>UDPIX</a>, <a href='https://seekingalpha.com/symbol/GSEW' title='Goldman Sachs Equal Weight U.S. Large Cap Equity ETF'>GSEW</a>, <a href='https://seekingalpha.com/symbol/ESGL' title='Oppenheimer ESG Revenue ETF'>ESGL</a>, <a href='https://seekingalpha.com/symbol/HUSV' title='First Trust Horizon Managed Volatility Domestic ETF'>HUSV</a>, <a href='https://seekingalpha.com/symbol/CHGX' title='Change Finance Diversified Impact U.S. Large Cap Fossil Fuel Free ETF'>CHGX</a>, <a href='https://seekingalpha.com/symbol/USSD' title='WisdomTree Strong Dollar U.S. Equity ETF'>USSD</a>, <a href='https://seekingalpha.com/symbol/DUSA' title='Davis Select U.S. Equity ETF'>DUSA</a>, <a href='https://seekingalpha.com/symbol/USWD' title='WisdomTree Weak Dollar U.S. Equity ETF'>USWD</a>, <a href='https://seekingalpha.com/symbol/BIBL' title='Inspire 100 ETF'>BIBL</a>, <a href='https://seekingalpha.com/symbol/PMOM' title='Principal Sustainable Momentum Index ETF'>PMOM</a>,&nbsp;<a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a>, <a href='https://seekingalpha.com/symbol/VOO' title='Vanguard S&P 500 ETF'>VOO</a>, <a href='https://seekingalpha.com/symbol/SH' title='ProShares Short S&P 500 ETF'>SH</a>, <a href='https://seekingalpha.com/symbol/SDS' title='ProShares UltraShort S&P 500 ETF'>SDS</a>, <a href='https://seekingalpha.com/symbol/IVV' title='iShares Core S&P 500 ETF'>IVV</a>, <a href='https://seekingalpha.com/symbol/SSO' title='ProShares Ultra S&P 500 ETF'>SSO</a>, <a href='https://seekingalpha.com/symbol/SPXU' title='ProShares UltraPro Short S&P 500 ETF'>SPXU</a>, <a href='https://seekingalpha.com/symbol/UPRO' title='ProShares UltraPro S&P 500 ETF'>UPRO</a>, <a href='https://seekingalpha.com/symbol/SPXL' title='Direxion Daily S&P 500 Bull 3x Shares ETF'>SPXL</a>, <a href='https://seekingalpha.com/symbol/RSP' title='Guggenheim S&P 500 Equal Weight ETF'>RSP</a>, <a href='https://seekingalpha.com/symbol/SPXS' title='Direxion Daily S&P 500 Bear 3x Shares ETF'>SPXS</a>, <a href='https://seekingalpha.com/symbol/VFINX' title='Vanguard 500 Index Fund Inv'>VFINX</a>, <a href='https://seekingalpha.com/symbol/EPS' title='WisdomTree Earnings 500 ETF'>EPS</a>, <a href='https://seekingalpha.com/symbol/SPLX' title='UBS ETRACS Monthly Reset 2xLeveraged S&P 500 total Return ETN'>SPLX</a>, <a href='https://seekingalpha.com/symbol/SPUU' title='Direxion Daily S&P 500 Bull 2x Shares ETF'>SPUU</a>, <a href='https://seekingalpha.com/symbol/SFLA' title='iPath Long Extended 3x S&P 500 Index TR Index ETN'>SFLA</a>, <a href='https://seekingalpha.com/symbol/SPDN' title='Direxion Daily S&P 500 Bear 1x Shares ETF'>SPDN</a>, <a href='https://seekingalpha.com/symbol/SPXE' title='ProShares S&P 500 Ex-Energy ETF'>SPXE</a>, <a href='https://seekingalpha.com/symbol/SPXT' title='ProShares S&P 500 Ex-Technology ETF'>SPXT</a>, <a href='https://seekingalpha.com/symbol/LLSP' title='Direxion Daily S&P 500 Bull 1.25X Shares'>LLSP</a>, <a href='https://seekingalpha.com/symbol/SPXV' title='ProShares S&P 500 Ex-Health Care ETF'>SPXV</a>, <a href='https://seekingalpha.com/symbol/RYARX' title='Rydex Inverse S&P 500 Strategy Fund A'>RYARX</a>, <a href='https://seekingalpha.com/symbol/SPXN' title='ProShares S&P 500 Ex-Financial ETF'>SPXN</a>, <a href='https://seekingalpha.com/symbol/DMRL' title='DeltaShares S&P 500 Managed Risk ETF'>DMRL</a>, <a href='https://seekingalpha.com/symbol/RVRS' title='Reverse Cap Weighted U.S. Large Cap ETF'>RVRS</a>, <a href='https://seekingalpha.com/symbol/USMC' title='Principal U.S. Mega-Cap Multi-Factor Index ETF'>USMC</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344131\" data-linked=\"China warns of  &#39;major response&#39; on trade\" data-tweet=\"$DIA $CRF $USA - China warns of &#39;major response&#39; on trade https://seekingalpha.com/news/3344131-china-warns-of-major-response-on-trade?source=tweet\" data-url=\"https://seekingalpha.com/news/3344131-china-warns-of-major-response-on-trade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>122&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344130\" data-ts=\"1523018938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344130-incyte-epacadostat-flop-weighing-on-certain-biotechs-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Incyte epacadostat flop weighing on certain biotechs premarket</a></h4><ul><li>Incyte is down&nbsp;<font color='red'>19%</font>&nbsp;premarket on robust volume after epacadostat failed to demonstrate a treatment benefit over Merck's Keytruda alone in a Phase 3 melanoma study. The selling has engulfed competitor NewLink Genetics, down&nbsp;<font color='red'>40%</font>&nbsp;premarket.</li><li>The sour mood is spreading to other biotechs. The SPDR S&amp;P Biotech ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a>) is down&nbsp;<font color='red'>1%</font>&nbsp;.</li><li>Selected tickers: Biogen (NASDAQ:<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a>) off a fraction; Amgen (NASDAQ:<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a>) down&nbsp;<font color='red'>1%</font>; Gilead Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>) off a fraction; Merck (NYSE:<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a>) down&nbsp;<font color='red'>1%</font>, Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) down&nbsp;<font color='red'>5%</font>; Nektar Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a>) down&nbsp;<font color='red'>5%</font>; OncoSec Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a>) down&nbsp;<font color='red'>4%</font>; GlycoMimetics (NASDAQ:<a href='https://seekingalpha.com/symbol/GLYC' title='GlycoMimetics'>GLYC</a>) down&nbsp;<font color='red'>1%</font>; AVEO Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a>) down&nbsp;<font color='red'>3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344130\" data-linked=\"Incyte epacadostat flop weighing on certain biotechs premarket\" data-tweet=\"$BIIB $XBI $BIIB - Incyte epacadostat flop weighing on certain biotechs premarket https://seekingalpha.com/news/3344130-incyte-epacadostat-flop-weighing-on-certain-biotechs-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3344130-incyte-epacadostat-flop-weighing-on-certain-biotechs-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344129\" data-ts=\"1523018751\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344129-jobs-weather-contributes-to-big-miss-bond-yields-slip\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More jobs: Weather contributes to big miss, bond yields slip</a></h4><ul><li>Alongside just 103K jobs added in March vs. 193K expected, January's 239K gain was revised down to 176K, and February's 313K gain was revised up to 326K. Combined, revisions took away 50K jobs previously thought to have been added. It sounds like a big miss, but March had some particularly nasty weather, and the BLS reports 259K as being unable to work because of it.</li><li>While headline unemployment held steady at 4.1%, the labor force participation rate slipped to 62.9% from 63%. The broader U6 unemployment rate fell to 8% from 8.2%.</li><li>The average workweek was steady at 34.5 hours, and average hourly earnings rose by $0.08 to $26.82. On a year-over-year basis, earnings are up 2.7%.</li><li>The 10-year Treasury yield has slipped a couple of basis points since the report, now down two bps to 2.81%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='green'>+0.5%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='red'>-1%</font></li><li>Gold (NYSEARCA:<a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>) is<font color='green'> up 0.4%</font>&nbsp;on the news, and the dollar (NYSEARCA:<a href='https://seekingalpha.com/symbol/UUP' title='PowerShares DB USD Bull ETF'>UUP</a>) has turned modestly lower.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344125-soft-jobs-march-103k-added-ue-rate-holding-4_1-percent\" target=\"_blank\">Soft jobs for March - 103K added, with UE rate holding at 4.1%</a> (April 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344129\" data-linked=\"More jobs: Weather contributes to big miss, bond yields slip\" data-tweet=\"$TLT $TBT $GLD - More jobs: Weather contributes to big miss, bond yields slip https://seekingalpha.com/news/3344129-jobs-weather-contributes-to-big-miss-bond-yields-slip?source=tweet\" data-url=\"https://seekingalpha.com/news/3344129-jobs-weather-contributes-to-big-miss-bond-yields-slip\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344124\" data-ts=\"1523017413\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CZR\" target=\"_blank\">CZR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344124-volatile-trading-on-caesars-entertainment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volatile trading on Caesars Entertainment</a></h4><ul> <li>Shares of Caesars Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment'>CZR</a>) are&nbsp;<font color='red'>down 13%</font>&nbsp;to $10 even on premarket volume of over 3K shares. The 52-week range on CZR is $9.45 to $14.50.</li> <li>Earlier this week, options trading on Caesars was listed by Bloomberg as among the most active in the U.S. at 3X normal activity.</li> <li>The volatility on Caesars picked up after a strong report on Las Vegas casino revenue during March.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3344124\" data-linked=\"Volatile trading on Caesars Entertainment\" data-tweet=\"$CZR - Volatile trading on Caesars Entertainment https://seekingalpha.com/news/3344124-volatile-trading-on-caesars-entertainment?source=tweet\" data-url=\"https://seekingalpha.com/news/3344124-volatile-trading-on-caesars-entertainment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344123\" data-ts=\"1523017327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTC-USD\" target=\"_blank\">BTC-USD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344123-bitcoin-continues-to-slide-interest-fades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin continues to slide as interest fades</a></h4><ul><li>If utter lack of interest is a condition for a bottom, perhaps the crypto bulls have something to be excited about here.</li><li>That Bitcoin (<a href='https://seekingalpha.com/symbol/BTC-USD' title='Bitcoin USD'>BTC-USD</a>) is&nbsp;<font color='red'>down another 3.3%</font>&nbsp;to $6.6K - close to the year's low and off about 70% from the all-time high - isn't huge news, but it certainly would have made for loud headlines a couple of months back. This morning, there's hardly a peep.</li><li>Ripple (<a href='https://seekingalpha.com/symbol/XRP-USD' title='XRP USD'>XRP-USD</a>) is<font color='red'> lower by 5%&nbsp;</font>to $0.46. Was it only January when that crypto was trading above $2 and at least one major financial news outlet was giving tutorials on how one might go about purchasing?</li><li>Ether (<a href='https://seekingalpha.com/symbol/ETH-USD' title='Ethereum USD'>ETH-USD</a>) is&nbsp;<font color='red'>off 3.9%</font>&nbsp;to $366, and Litecoin (<a href='https://seekingalpha.com/symbol/LTC-USD' title='Litecoin USD'>LTC-USD</a>) is&nbsp;<font color='red'>down 4.4%</font>&nbsp;to $113.</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/BTLLF' title='Interbit Ltd.'>OTCPK:BTLLF</a> <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a>, <a href='https://seekingalpha.com/symbol/COINB' title='Coinbase'>COINB</a>, <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3344123\" data-linked=\"Bitcoin continues to slide as interest fades\" data-tweet=\"$BTC-USD $BTC-USD $XRP-USD - Bitcoin continues to slide as interest fades https://seekingalpha.com/news/3344123-bitcoin-continues-to-slide-interest-fades?source=tweet\" data-url=\"https://seekingalpha.com/news/3344123-bitcoin-continues-to-slide-interest-fades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>140&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344121\" data-ts=\"1523017183\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INCY\" target=\"_blank\">INCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344121-incytes-late-stage-epacadostat-flop-pressures-newlink-genetics-down-32-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Incyte&#39;s late-stage epacadostat flop pressures NewLink Genetics, down 32% premarket</a></h4><ul><li>Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) is down&nbsp;<font color='red'>17%</font>&nbsp;premarket on the heels of a failed late-stage study of IDO1 inhibitor epacadostat in melanoma. The disappointing outcome is weighing on NewLink Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/NLNK' title='NewLink Genetics Corporation'>NLNK</a>), down&nbsp;<font color='red'>32%</font>&nbsp;premarket on modestly higher volume.</li><li>NewLink's core focus is IDO inhibition, including lead candidate indoximod.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344107-incytes-epacadostat-flunks-late-stage-melanoma-study\" target=\"_blank\">Incyte's epacadostat flunks late-stage melanoma study</a> (April 6)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3297286-newlink-teams-astrazeneca-evaluate-indoximod-durvalumab-combo-pancreatic-cancer-shares-ahead\" target=\"_blank\">NewLink teams up with AstraZeneca to evaluate indoximod/durvalumab combo in pancreatic cancer; shares ahead 8% premarket</a> (Sept. 25, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344121\" data-linked=\"Incyte&#39;s late-stage epacadostat flop pressures NewLink Genetics, down 32% premarket\" data-tweet=\"$INCY $INCY $NLNK - Incyte&#39;s late-stage epacadostat flop pressures NewLink Genetics, down 32% premarket https://seekingalpha.com/news/3344121-incytes-late-stage-epacadostat-flop-pressures-newlink-genetics-down-32-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3344121-incytes-late-stage-epacadostat-flop-pressures-newlink-genetics-down-32-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344110\" data-ts=\"1523015950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRSP\" target=\"_blank\">CRSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344110-goldman-bullish-on-crispr-therapeutics-sees-100-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman bullish on CRISPR Therapeutics, sees 100% upside</a></h4><ul><li>Goldmans Sachs pegs gene editor CRISPR Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a>) with a Street-high $86 price target &#40;BUY&#41;. Analyst Salveen Richter says the takeout price for the CRISPR/Cas9 player could be as high as $148 per share.</li><li>She also likes the prospects for CTX001, partnered with Vertex Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a>), for blood disorders and sickle cell disease since it is a different approach to the conditions.</li><li>Shares are up&nbsp;<font color='green'>3%</font>&nbsp;premarket on light volume.</li><li>Source: Bloomberg</li><li>Related tickers: (NASDAQ:<a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics'>NTLA</a>)(NASDAQ:<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344110\" data-linked=\"Goldman bullish on CRISPR Therapeutics, sees 100% upside\" data-tweet=\"$CRSP $CRSP $VRTX - Goldman bullish on CRISPR Therapeutics, sees 100% upside https://seekingalpha.com/news/3344110-goldman-bullish-on-crispr-therapeutics-sees-100-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3344110-goldman-bullish-on-crispr-therapeutics-sees-100-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344111\" data-ts=\"1523015336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344111-nomura-defends-micron-shares-down-another-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nomura defends Micron; shares down another 3% premarket</a></h4><ul><li>Following meetings with new CFO David Zisner, Nomura's Romit Shah maintains his Buy rating and $100 price target (<font color='green'>100% upside</font>&nbsp;from yesterday's close).</li><li>He doesn't foresee a large jump in capex, and says earnings power of $12-$14 per share over the next year is still the case.</li><li>Source: Bloomberg</li><li>Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>)&nbsp;<font color='red'>fell 6.65%</font>&nbsp;yesterday after <a href=\"https://seekingalpha.com/news/3343872-ubs-initiates-micron-34-percent-downside-upcoming-dram-wave\" target=\"_blank\">a nasty downgrade</a> from UBS. It's&nbsp;<font color='red'>lower by another 3.3%</font>&nbsp;in premarket action to $48.20.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344111\" data-linked=\"Nomura defends Micron; shares down another 3% premarket\" data-tweet=\"$MU - Nomura defends Micron; shares down another 3% premarket https://seekingalpha.com/news/3344111-nomura-defends-micron-shares-down-another-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3344111-nomura-defends-micron-shares-down-another-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>125&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344107\" data-ts=\"1523015014\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INCY\" target=\"_blank\">INCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344107-incytes-epacadostat-flunks-late-stage-melanoma-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Incyte&#39;s epacadostat flunks late-stage melanoma study</a></h4><ul><li>Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) <a href=\"https://seekingalpha.com/pr/17122421-incyte-merck-provide-update-phase-3-study-epacadostat-combination-keytruda-pembrolizumab\" target=\"_blank\">announces </a>that a Phase 3 clinical trial, ECHO-301/KEYNOTE-252 evaluating the combination of epacadostat and Merck's (NYSE:<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a>) KEYTRUDA (pembrolizumab) in patients with unresectable/metastatic melanoma failed to demonstrate a statistically valid improvement in progression-free survival &#40;PFS&#41; compared to KEYTRUDA alone.</li><li>The secondary endpoint of overall survival &#40;OS&#41; is not expected to be met either. The study will be terminated.</li><li>Chief Medical Officer Steven Stein, M.D., says, &ldquo;While we are disappointed that this study did not confirm the efficacy of epacadostat in combination with KEYTRUDA in patients with unresectable or metastatic melanoma, data from ECHO-301/KEYNOTE-252, including analyses of an extensive biomarker panel, will contribute to our understanding of the role of IDO1 inhibition in combination with PD-1 antagonists, and may inform our broader epacadostat clinical development program. We remain dedicated to transforming the treatment of cancer and will continue to explore how IDO1 inhibition and other novel mechanisms can potentially improve outcomes for patients in need.&rdquo;</li><li>Shares will resume trading at 8:00 am ET.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344107\" data-linked=\"Incyte&#39;s epacadostat flunks late-stage melanoma study\" data-tweet=\"$INCY $INCY $MRK - Incyte&#39;s epacadostat flunks late-stage melanoma study https://seekingalpha.com/news/3344107-incytes-epacadostat-flunks-late-stage-melanoma-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3344107-incytes-epacadostat-flunks-late-stage-melanoma-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344105\" data-ts=\"1523014986\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEWM\" target=\"_blank\">NEWM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344105-new-media-investment-group-down-10_11-after-share-pricing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Media Investment Group down 10.11% after share pricing</a></h4><ul> <li>New Media Investment Group (NYSE:<a href='https://seekingalpha.com/symbol/NEWM' title='New Media'>NEWM</a>) expects gross proceeds of ~$99M from its 6M share offering, suggesting a <a href=\"https://seekingalpha.com/pr/17122395-new-media-announces-pricing-public-offering-common-stock\" target=\"_blank\">price</a> of $16.50 per share.</li><li>Underwriters over-allotment is an additional 900K shares.</li><li>The offering is expected to       close on April 10.</li>     <li>NEWM&nbsp;<font color='red'>-10.11%</font>&nbsp;premarket to $15.65.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344029-new-media-files-mixed-shelf-6m-shares\" target=\"_blank\">New Media files mixed shelf for 6M shares</a> (April 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344105\" data-linked=\"New Media Investment Group down 10.11% after share pricing\" data-tweet=\"$NEWM - New Media Investment Group down 10.11% after share pricing https://seekingalpha.com/news/3344105-new-media-investment-group-down-10_11-after-share-pricing?source=tweet\" data-url=\"https://seekingalpha.com/news/3344105-new-media-investment-group-down-10_11-after-share-pricing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344106\" data-ts=\"1523014524\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344106-amazon-mulls-getting-payments-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon mulls getting into the payments business</a></h4><ul><li>\"Alexa, pay Joe $100\" may be in our future. Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) is considering adding a person-to-person payments feature to Alexa, <a href=\"https://www.wsj.com/articles/hey-alexa-can-you-help-amazon-get-into-the-payments-business-1523007000\" target=\"_blank\">according to the <em>WSJ</em></a>.</li><li>Such a feature would put the margin-killing machine in direct competition with PayPal (NASDAQ:<a href='https://seekingalpha.com/symbol/PYPL' title='PayPal Holdings, Inc.'>PYPL</a>) and Square (NYSE:<a href='https://seekingalpha.com/symbol/SQ' title='Square, Inc.'>SQ</a>), with Visa (NYSE:<a href='https://seekingalpha.com/symbol/V' title='Visa Inc.'>V</a>) and MasterCard (NYSE:<a href='https://seekingalpha.com/symbol/MA' title='Mastercard, Inc.'>MA</a>) also in the sights. It's also <a href=\"https://seekingalpha.com/news/3336314-amazon-coming-bank-margins\" target=\"_blank\">part of a boarder move</a> by the company to enter the world of banking and finance.</li><li>Square is&nbsp;<font color='red'>down 2.2%</font>&nbsp;and PayPal&nbsp;<font color='red'>1.2%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344106\" data-linked=\"Amazon mulls getting into the payments business\" data-tweet=\"$AMZN $AMZN $PYPL - Amazon mulls getting into the payments business https://seekingalpha.com/news/3344106-amazon-mulls-getting-payments-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3344106-amazon-mulls-getting-payments-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>83&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344104\" data-ts=\"1523014055\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INCY\" target=\"_blank\">INCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344104-incyte-shares-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Incyte shares halted pending news</a></h4><ul><li>Nasdaq has <a href=\"http://www.nasdaqtrader.com/trader.aspx?id=tradehalts\" target=\"_blank\">suspended trading </a>in Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) pending the release of news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344104\" data-linked=\"Incyte shares halted pending news\" data-tweet=\"$INCY - Incyte shares halted pending news https://seekingalpha.com/news/3344104-incyte-shares-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3344104-incyte-shares-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344095\" data-ts=\"1523012305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETH\" target=\"_blank\">ETH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344095-ethan-allen-drops-after-fq3-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ethan Allen drops after FQ3 update</a></h4><ul> <li>Ethan Allen (NYSE:<a href='https://seekingalpha.com/symbol/ETH' title='Ethan Allen Interiors Inc.'>ETH</a>) trades lower after posting preliminary FQ3 results below consensus estimates.</li> <li>The retailer reports revenue of $181.3M during the quarter vs. $188.0M consensus.</li> <li>Retail division written orders increased 2.6% during the quarter, driven higher by a strong acceleration in March of 6.9%. Wholesale orders increased by 14%, helped by strong orders from the U.S. government.</li> <li>CEO update: \"We are well positioned to grow our sales and profits, as many of our major initiatives are in place, and remain cautiously optimistic.\"</li><li><a href=\"https://seekingalpha.com/filing/3968558\" target=\"_blank\">SEC Form 8-K</a></li> <li>Shares of Ethan Allen are <font color='red'>down 1.51%</font> premarket to $22.85.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344095\" data-linked=\"Ethan Allen drops after FQ3 update\" data-tweet=\"$ETH - Ethan Allen drops after FQ3 update https://seekingalpha.com/news/3344095-ethan-allen-drops-after-fq3-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3344095-ethan-allen-drops-after-fq3-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344090\" data-ts=\"1523011517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNKD\" target=\"_blank\">MNKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344090-mannkind-prices-28m-private-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MannKind prices $28M private stock offering</a></h4><ul><li>MannKind (NASDAQ:<a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a>) <a href=\"https://seekingalpha.com/pr/17122354-mannkind-announces-28_0-million-registered-direct-offering\" target=\"_blank\">prices its direct offering</a> of 14M shares of common stock at $2.00 per share to certain institutional investors. Each share sold will have an accompanying six-month warrant to purchase one share of common at $2.38. Gross proceeds will be $28M. Closing date is April 10.</li><li>Net proceeds of ~$26.3M will be used for general corporate purposes.</li><li>Yesterday's close was $2.38.</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>17%</font>&nbsp;premarket on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344090\" data-linked=\"MannKind prices $28M private stock offering\" data-tweet=\"$MNKD - MannKind prices $28M private stock offering https://seekingalpha.com/news/3344090-mannkind-prices-28m-private-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3344090-mannkind-prices-28m-private-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344087\" data-ts=\"1523011127\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDXS\" target=\"_blank\">CDXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344087-codexis-prices-stock-offering-9_25-shares-down-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Codexis prices stock offering at $9.25; shares down 10% premarket</a></h4><ul><li>Codexis (NASDAQ:<a href='https://seekingalpha.com/symbol/CDXS' title='Codexis, Inc.'>CDXS</a>) slips<font color='red'> 10%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17122333-codexis-announces-pricing-public-offering-common-stock\" target=\"_blank\">public offering</a> of 3.75M shares of common stock at $9.25 per share. Underwriters over-allotment is an additional 562.5K shares. Closing date is April 10.</li><li>Net proceeds will be used for general corporate purposes. Yesterday's close was $10.70.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344087\" data-linked=\"Codexis prices stock offering at $9.25; shares down 10% premarket\" data-tweet=\"$CDXS - Codexis prices stock offering at $9.25; shares down 10% premarket https://seekingalpha.com/news/3344087-codexis-prices-stock-offering-9_25-shares-down-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3344087-codexis-prices-stock-offering-9_25-shares-down-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344079\" data-ts=\"1523007810\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGM\" target=\"_blank\">MGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344079-mgm-said-to-approached-wynn-resorts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MGM said to have approached Wynn Resorts</a></h4><ul>     <li>MGM Resorts (NYSE:<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a>) has made \"back-channel\" approaches to Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) about a <a href=\"https://nypost.com/2018/04/05/mgm-resorts-may-roll-the-dice-and-buy-wynn-resorts/\" target=\"_blank\">takeover</a>, according to the New York Post.</li>     <li>While Wynn Resorts isn't on the block, sources indicate that the company would sell at the right price.</li>     <li>The lack of any board additions at Wynn is seen as a signal that a deal could be brewing.</li>     <li>Shares of Wynn are <font color='green'>up 2.41%</font> premarket to $185.60.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344079\" data-linked=\"MGM said to have approached Wynn Resorts\" data-tweet=\"$MGM $MGM $WYNN - MGM said to have approached Wynn Resorts https://seekingalpha.com/news/3344079-mgm-said-to-approached-wynn-resorts?source=tweet\" data-url=\"https://seekingalpha.com/news/3344079-mgm-said-to-approached-wynn-resorts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344075\" data-ts=\"1523006666\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344075-facebooks-sandberg-talks-paid-product\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook&#39;s Sandberg talks paid product</a></h4><ul>     <li>The media blitz by Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a>) Chief Operating Officer Sheryl Sandberg included an <a href=\"https://www.axios.com/sansers-would-have-to-pay-to-opt-out-of-all-facebook-ads-1522981231-dceced0c-10bd-49d3-9375-419a7596612a.html\" target=\"_blank\">appearance</a> on NBC in an interview set to air today.</li><li>Sandberg said Facebook users would have to pay a fee to avoid all user data-targeted advertisements. \"We don't have an opt-out at the highest level... That would be a paid product,\" stated Sandberg.</li><li>Shares of Facebook are <font color='red'>down 1.17%</font> premarket after jumping 2.73% yesterday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344075\" data-linked=\"Facebook&#39;s Sandberg talks paid product\" data-tweet=\"$FB - Facebook&#39;s Sandberg talks paid product https://seekingalpha.com/news/3344075-facebooks-sandberg-talks-paid-product?source=tweet\" data-url=\"https://seekingalpha.com/news/3344075-facebooks-sandberg-talks-paid-product\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>79&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":67,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}